Magneettikuvaukseen perustuvan sädehoidon suunnittelun käyttöönotto lantion alueella by Kemppainen, Reko
 
 
 
 
 
 
Commissioning of MRI-only simulation 
for radiotherapy planning in pelvis 
 
   
 
 
Reko Kemppainen 
 
 
 
Licentiate thesis 
Doctoral Programme in Science 
  11-Dec-2019 
 
  Supervisor: Professor Risto Ilmoniemi  
  Advisor: Jani Keyriläinen, Timo Kiljunen, Marko Pesola 
 
 
 
Aalto University 
Name of School 
Name of Department 
Research group  
 Aalto University, P.O. BOX 11000, 00076 AALTO 
www.aalto.fi 
Abstract of licentiate thesis 
 
 
Author Reko Kemppainen 
Title of thesis Commissioning of MRI-only simulation for radiotherapy planning in pelvis 
Department Department of Neuroscience and Biomedical Engineering 
Field of research Neuroscience and biomedical engineering 
Supervising professor Risto Ilmoniemi 
Thesis advisor(s) Jani Keyriläinen, Timo Kiljunen, Marko Pesola 
Thesis examiner(s) Juha Nikkinen 
Number of pages 41 Language English 
Date of submission for examination 23.10.2019 
Abstract 
Modern radiation therapy delivery techniques enable ever conformal delivery of the radiation in-
creasing the likelihood for successful treatment and reducing complications in nearby healthy tis-
sue. In order to improve the treatment outcomes, in addition to advanced radiation delivery tech-
niques, more accurate knowledge about the location and spread of both disease and organs at risk 
(OAR) is needed. Thus, the use of magnetic resonance imaging (MRI) has increased substantially 
during recent years. In MRI, the contrast resolution for soft tissue is superior compared to other 
imaging modalities enabling precise target definition and contouring of the OARs. 
Currently, the use of MRI in radiation therapy is based on co-registration of the images facilitating 
the use of the information provided by MRI while computed tomography (CT) is used for dose com-
putation and as a reference image for patient positioning. Unfortunately, the dual modality work-
flow is laborious and cost inefficient. In addition, the co-registration uncertainty propagates to treat-
ment uncertainty causing systematic error. During recent years several research groups have pub-
lished methods enabling the generation of so-called synthetic CT (sCT). It can be used like tradi-
tional CT for density information in dose computation and as positioning reference images. The use 
of sCT enables external beam radiation therapy workflow using only MR imaging. 
In this work we studied the commissioning and accuracy of MRI-only workflow for external beam 
radiation therapy (EBRT) of pelvic malignancies. The commissioning test shall cover all steps in the 
radiation therapy workflow where geometric or dosimetric accuracy is affected by the substitution 
of the CT by the sCT.  
In publications I and III, we assessed the dosimetric accuracy of sCT images in pelvis by comparing 
to dose distributions computed using CT images. In publications II and III, we studied the patient 
positioning accuracy when sCT images are used as reference images. In addition, in publications I 
and III we evaluated the impact of geometric distortions to the total accuracy of MRI-only workflow. 
According to our results, the use of studied sCT method is sufficiently accurate for clinical use for 
pelvic indications. In addition, image-guided radiation therapy based on MR images is accurate 
enough so that the total geometric accuracy improves compared to current CT based workflow.  
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Tiivistelmä 
Modernit sädehoitotekniikat mahdollistavat yhä tarkemman kohteenmukaisen sädehoidon antami-
sen, mikä lisää hoidon onnistumisen todennäköisyyttä ja vähentää komplikaatioita ympäröivissä 
terveissä kudoksissa. Parempiin hoitotuloksiin pääsemiseksi sädehoidossa tarvitaan kuitenkin, ke-
hittyneiden hoitotekniikoiden lisäksi, yhä tarkempaa tietoa hoitokohteen ja riskielinten sijainnista. 
Tämän takia ionisoimattoman säteilyn käyttöön perustuvan magneettikuvauksen (MK) käyttö on 
lisääntynyt voimakkaasti sädehoidossa viime vuosina. MK:ssa pehmytkudosten välinen kontrasti on 
muita kuvausmodaliteetteja parempi, mikä mahdollistaa tarkemman kohteen määrittelyn ja riskie-
linten rajauksen.  
Nykyinen käytäntö MK-kuvien osalta sädehoidossa perustuu tietokonetomografia- (TT) ja MK-ku-
vien rekisteröintiin, jolloin MK-kuvien antama lisäinformaatio voidaan hyödyntää, vaikka itse hoi-
tokenttien annoslaskenta ja potilaan kohdistus on TT-kuviin perustuvaa. Kahden kuvausmodalitee-
tin käytöstä aiheutuu ylimääräistä työtä ja kustannuksia. Lisäksi kuvien rekisteröintiin liittyvä virhe 
lisää epävarmuutta hoidon tarkkuudessa. Viime aikoina useat tutkimusryhmät ovat julkaisseet me-
netelmiä, joiden avulla on mahdollista muodostaa sädehoidon annoslaskennassa tarvittava tiheys-
kartta (laskennallinen TT-kuva) suoraan magneettikuvausta käyttäen. Näin sädehoito on mahdol-
lista toteuttaa pelkän magneettikuvan perusteella, jolloin yllä mainitut kahden kuvausmodaliteetin 
käytöstä aiheutuvat ongelmat voidaan välttää.  
Tässä työssä tutkittiin MK-kuviin perustuvan laskennallisen TT-kuvan käyttöönottoa ja tarkkuutta 
lantion alueen ulkoisessa sädehoidossa. Käyttöönotto-testien tulee kattaa kaikki sellaiset vaiheet, 
jossa MK-pohjainen suunnittelu vaikuttaa joko geometriseen tai dosimetriseen tarkkuuteen.  
Ensimmäisessä ja kolmannessa osatyössä tutkittiin mahdollisuutta käyttää MK:ta sädehoitopotilai-
den lantion alueen annoslaskennassa säteilyn vaimennuskorjaukseen. Toisessa ja kolmannessa osa-
työssä määritettiin potilasasemoinnin epätarkkuus käytettäessä MK-pohjaista menetelmää vertaa-
malla perinteiseen TT-kuvaan pohjautuvaan menetelmään. Lisäksi ensimmäisessä ja kolmannessa 
osatyössä arvioitiin MK:n geometrisen vääristymän vaikutuksia kokonaistarkkuuteen. 
Tutkimuksen perusteella menetelmän käyttö lantion alueella on riittävän tarkka kliiniseen käyt-
töön. Lisäksi kuvantaohjattu sädehoito magneettikuvien pohjalta on riittävän tarkkaa, jotta potilaan 
asemointitarkkuus ei huonone suhteessa nykyiseen TT-pohjaiseen suunnitteluun.  
Avainsanat  Sädehoito, MRI, Käyttöönotto 
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1. Introduction 
1.1 Background and research environment 
1.1.1 Radiotherapy workflow  
The use ionizing radiation as part of cancer treatment to control or kill malig-
nant cells and typically delivered by a linear accelerator, is called radiation ther-
apy (RT). Most commonly, RT is planned individually using computed tomog-
raphy (CT) image of the patient. The initial CT-scanning performed in the treat-
ment position with fixation devices is called RT simulation. The RT simulation 
forms the basis for treatment geometry and for both target and organ at risk 
(OAR) contouring. Contouring is preceded by dose planning. In the dose plan-
ning beam geometry and radiation delivery are planned and expected dose map 
is computed using the radiation attenuation information provided by the CT im-
age (see Figure 1 for illustration of the complete RT workflow). 
RT is delivered in fractionated manner – the total prescribed dose is frac-
tioned and delivered sequentially during several days or weeks. During each 
treatment fraction, the patient is first positioned and then the patient position 
is verified by imaging. In image-guided radiation therapy (IGRT), X-ray images 
of the patient, taken in the treatment position, are compared to reference im-
ages derived from the planning CT. Patient position verification ensures that the 
fractionated dose is delivered to the planned target for each fraction.  
1.1.2 Radiotherapy planning using MRI 
Computed tomography (CT) is currently the primary imaging modality for 
providing anatomical and tissue density information in the external beam radi-
ation therapy (EBRT) planning of pelvic cancers. Magnetic resonance imaging 
(MRI) is widely used as a supplement to the CT imaging [1–3]. The most signif-
icant advantage of MRI over CT is its better soft-tissue contrast, which results 
in a more accurate gross tumor volume (GTV) and OAR delineation [4–7]. Ad-
ditional benefits include the usage of non-ionizing radiation and the versatility 
of acquisition sequences allowing the cancer- or organ-specific imaging meth-
ods [5]. 
A major drawback of multi-modality imaging in EBRT is the residual registra-
tion error remaining when the images from two or more modalities are regis-
tered with each other [8]. Recent advances in the use of MRI promise to elimi-
nate the registration error by using only the MR images for planning and dose 
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calculation in the EBRT of prostate and brain cancer (see the recent reviews [9–
11]). In an MRI-only workflow, so-called synthetic CT (sCT) images are gener-
ated from the magnetic resonance (MR) images, providing the tissue density 
information for dose calculation and reference images for patient position veri-
fication.  
The sCT replaces CT image completely in the radiotherapy workflow called 
MRI-only (see Figure 1) workflow. Consequently, the parts in the CT-based 
workflow relying properties of the CT will be affected. Sites considering com-
missioning of MRI-only workflow into clinical use need to assure that the com-
plete chain of RT remains within acceptable tolerances. 
 
 Figure 1: CT‐based (left) and synthetic CT  (sCT)‐based radiotherapy workflow.  In CT‐based workflow 
image co‐registration may be omitted when using only MR images for the whole process (MRI‐only). 
However, use of  sCT  in an MRI‐only workflow affects geometric accuracy  requirements  for  the MR‐
imaging, treatment planning, dose computation and patient position verification (red). 
1.1.3 Synthetic CT used in this work 
A commercially available solution for the sCT generation was used in this work 
(MRCAT, Philips Oy, Vantaa, Finland). It has been shown that the solution can 
be used for an accurate dose calculation and patient positioning for prostate 
Materials and Methods 
cancer patients [1–3]. In addition, its feasibility for other indications in the pel-
vic anatomy was demonstrated in our study [4].  
During recent years, several sites have performed commissioning of commer-
cial MRI-only solutions, and results have been published in peer-reviewed pub-
lications [1–8]. In addition some hospitals have reported the clinical use of an 
inhouse solution (see e.g. [9]). 
Prior to clinical use of an MRI-only method, all aspects affecting the total ac-
curacy of the treatment must be evaluated, a process called commissioning. In 
particular, dosimetric and geometric accuracy must be quantitatively evaluated 
so that the impact to total treatment accuracy can be evaluated and accepted for 
clinical use. 
1.2 Objectives and scope 
In external radiation therapy (EBRT), the aim is to deliver prescribed dose to 
defined target with very high accuracy requirements. The high requirements are 
a consequence of a close physical proximity and radiobiological sensitivity of 
OARs and clinical target volume (CTV). Consequently, dosimetric and geomet-
ric accuracy is directly related to treatment outcomes in EBRT. 
The workflow of radiation therapy can be considered as a chain. From each 
link of the chain, accumulation of uncertainties occurs, and high accuracy is 
needed in all steps of the treatment process to ensure acceptable total uncer-
tainty. The total uncertainty of the RT workflow is a sum of the uncertainties 
from each step in the workflow [10]. The MRI-only workflow affects three items 
in the chain: geometric accuracy from imaging, treatment planning and patient 
position verification (see  
Figure 2). 
 
  
Figure 2: Components of the RT chain contributing to the total accuracy and uncertainties of the RT 
workflow. The components of the total uncertainty affected using sCT are illustrated as red.
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Geometric accuracy of the planning sCT image introduces systematic uncer-
tainties to both geometric and dosimetric accuracy. Thus, the geometric accu-
racy of sCT plays a critical role in MRI-only workflow. MRI images are inher-
ently distorted due to gradient field nonlinearity and both system and patient 
related inhomogeneities in the main magnetic field [11–15]. Since the distortion 
in the MR images will be propagated to the sCT, it is important to quantitatively 
assess the magnitude of distortion and its impact to dosimetric computation. 
In a sCT image, the HU values need to be derived from MRI. Since there is no 
direct association between MR image intensity on electron density of the tissue, 
estimated HU-values contain uncertainties. The introduced uncertainties will 
compromise the dose calculation accuracy achievable when using the sCT. Thus, 
prior to clinical use, the dosimetric differences need to be analyzed. 
In addition to uncertainties in HU unit of the sCT, also the appearance of the 
image will differ from CT. Depending on the sCT generation method the appear-
ance can be bulky, when small amount of differing HU values are used, or it can 
have a continuum of HU values like a real CT. However, the differences between 
sCT and CT may impact the image registration process occurring in the patient 
position verification. Thus, the impact to positioning accuracy needs to be as-
sessed in a realistic use scenario. 
Overall, the purpose of the commissioning is to ensure that the chain of RT is 
acceptable.  
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2. Aims of the thesis 
The primary focus of the work presented in this thesis was the commissioning 
and the quantitative assessment of a commercial MRI-only method for pelvic 
external beam radiation therapy. The specific aims were:   
 
- To perform an evaluation of the dosimetric accuracy of use of a com-
mercially available MRI-only for radiation therapy of pelvic malignan-
cies (Paper I and III).  
- To evaluate the accuracy and precision of patient positioning using a 
commercially available sCT generation method for pelvic radiotherapy 
(Paper II and III).  
- To evaluate the impact of geometric distortion in MRI-only based ra-
diation therapy of pelvic malignancies (Papers I and III).   
   
Materials and methods 
3. Materials and methods 
3.1 Generation of synthetic CTs 
Two different versions of synthetic CT (sCT) were used in the study. Both ver-
sions have been released as commercial MRI-only solutions (Magnetic reso-
nance for Calculating Attenuation, MRCAT, Philips Oy, Vantaa, Finland). The 
first version used a bulk assignment of HU values, which is referred to as sCTb 
in this study. The second version was an improved version of the MRCAT 
providing continuous HU values called sCTc hereafter. 
Generation of the sCT is based on mDIXON MR image [16]. Bone structures 
in the sCT are automatically segmented inside the body using the multiple con-
trasts provided by the mDIXON scan. Both the bone and outline segmentation 
employ a model-based segmentation approach trained on patient and volunteer 
mDIXON image datasets. The model contains information of average bone 
shape and how the shape varies in the training population. The model is adapted 
to an actual patient image using features (such as gray value edges) found within 
the image, while at the same time, a constraint for the shape of the segmented 
structure prevents the segmentation from being attracted to a wrong position 
[17].  
Voxels inside the bone segmentation are assumed to contain either compact 
or spongy bone. An intensity threshold is used; lower intensities are considered 
to consist of compact bone, while voxels with higher intensity are assumed to 
contain spongy bone. The choice of the threshold value has been selected so that 
average bone density match with CT on population level. Figure 3 shows the 
flowchart for the prostate (bulk HU value) sCTb algorithm. 
The same flowchart applies also to the sCTc algorithm. In particular, the sCTc 
algorithm also relies on the availability of a body mask and a bone mask.  Like 
for sCTb, classification between fat tissue and water tissue is based on the fat 
and water intensities in the respective sCT source images. The key difference 
between the sCTb and sCTc algorithms is in the assignment of the HU values—
in sCTc, the classification between fat and water is continuous. The HU values 
are interpolated linearly between the respective limit values for soft tissue.  
In sCTb, bone voxels are classified as either compact bone or bone marrow. In 
sCTc, the compactness is described with a continuous-valued bone index. The 
bone index is converted into a HU value through a piecewise-linear mapping.  
The outmost body layer, representing skin, can also be classified as partially 
air. This models the partial volume effect.  
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Figure 3: Flowchart for the bulk and continuous HU value sCT algorithm. The continuous‐value sCT al‐
gorithm is otherwise similar, but the soft tissue classification and the bone tissue classification are 
continuous‐valued instead of discrete. The HU values are respectively interpolated continuously. 
The assignment of continuous HU value starts by estimating the centers of fat-
rich and water-rich voxel clusters. The soft tissue voxels are mapped continu-
ously between water and fat clusters. The voxel intensities in the water-fat-plane 
are projected to a line, which connects the cluster centers. Fat fraction 𝑥𝑓𝑎𝑡 is 
defined such that 𝑥fatൌ0 at the water center and 𝑥fatൌ1 at the fat center. The com-
plement of the fat fraction is water fraction 𝑥waterൌ1െ𝑥fat. In the outmost body 
layer, the relation between fat and water fractions is modified by the presence 
of air fraction. The air fraction in the outermost voxel layer of the body mask is 
quantified using normalized voxel intensity. 
Dense bone manifests on the mDixon images as voxels with low signal inten-
sity. Hence, the voxels within the bone mask are classified according to their 
“darkness”, i.e. the distance of the voxels from the water-fat classification line.  
Fat and water fractions and bone index are mapped to HU values using a lin-
ear fitting. A single linear fit is used for soft tissue, while for bone tissue, a two-
staged polyline is used to distinguish between spongy bone and compact bone. 
3.2 Performance evaluations of MRI-only methods 
To ascertain that sCT can meet high demands for dosimetric and geometric ac-
curacy, medical physicists perform commissioning of MRI-only simulation 
prior to clinical use. In commissioning, all aspects related to the performance of 
the method need to be assessed including dosimetric agreement, geometric and 
patient positioning accuracy. 
3.2.1 Dosimetric accuracy 
When computed tomography (CT) is used for homogeneity correction of ex-
ternal beam dose calculation, one can always verify the correctness of calcula-
tions by measuring the absorbed dose in a phantom. The mapping between HUs 
and electron or mass density can be regarded correct if the delivered dose inside 
Materials and methods 
a phantom is within acceptable dose accuracy tolerance. A fundamental prop-
erty of MRI-only methods is that the dosimetric accuracy can’t be measured di-
rectly as sCT methods don’t provide meaningful images of phantoms. Conse-
quently, performance must be evaluated by comparing to current gold standard, 
i.e., CT-based dose computation. 
 
Table 1: Patient demographics in dosimetric agreement studies (Publications I and III). 
 
Pelvic lymph 
node 
Rectal can‐
cer 
Gynecological 
cancer 
Prostate post‐
operative 
Prostate 
definitive 
Publication I     
Average age (years)   65.7 (6.2) 68.2 (10.6) 67.3 (14.0) 68.7 (6.8)  70.3 (8.0)
Sex (males/fe‐
males)  15/0  10/5 0/15 15/0 15/0 
Publication III     
Average age (years)   ‐  69.2 (12.8)  72.8 (8.3)  ‐  74.3 (4.8) 
Sex (males/fe‐
males)  ‐  3/2 0/5 ‐ 5/0 
 
For dose agreement assessment, CT and sCT images were first registered and 
then resampled to the same image grid. The clinical radiotherapy plan, origi-
nally optimized using the planning CT, was then copied to sCT and recomputed 
to the same dose grid (see Figure 4 for illustration of the workflow). 
The dose distributions were computed with Eclipse 13.6 (Varian Medical Sys-
tems Finland Oy, Helsinki, Finland) treatment planning system (TPS) using an 
anisotropic analytical algorithm (AAA) (publication III) or Pinnacle3 (version 
9.10, Philips Medical Systems Inc., Fitchburg, WI, USA) TPS with collapsed 
cone algorithm (publication I). Computed doses were used to compute both 
DVH and gamma comparisons. 
The DVH evaluation was based on the structures that were copied from the 
planning CT to sCT based on rigid registration. Minimum, median and maxi-
mum (D2%, D50%, D98%) dose points were evaluated for the PTVs while volumes 
of V95% and V70% were assessed for the OARs. The results were computed as a 
relative difference respect to prescribed dose for dose points (𝑫ሺ𝒔𝑪𝑻ሻି𝑫ሺ𝑪𝑻ሻ𝑫𝒑𝒓𝒆𝒔𝒄. ) or 
structure volume (𝑽ሺ𝒑𝑪𝑻ሻି𝑽ሺ𝑪𝑻ሻ𝑽𝒔𝒕𝒓𝒖𝒄𝒕. ) for volume points. 
In addition, the dose distributions between sCT and planning CT were com-
pared by means of 3D gamma analysis using the Plastimatch 1.7.3 (http://plas-
timatch.org/index.html), an open source software for image processing, (publi-
cation III). 
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 Figure 4: The workflow for dosimetric agreement evaluation. First, CT and sCT were rigidly registered 
and resampled to the same image grid (image rotation exaggerated for the sCT). Resampling ensures 
identical dose computation grid for further analysis when the radiotherapy plan is copied from CT to 
sCT. The differences between the two dose distributions were analyzed by means of dose volume his‐
togram (DVH) differences, voxel‐wise dose differences and using 3D gamma analysis. 
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3.2.2 Patient positioning accuracy 
Patient position verification is a procedure during a radiotherapy treatment 
fraction where the position and orientation of the patient is compared to 
planned positioning. Patient position verification enables accurate delivery of 
the fractionated dose to the target.  
Modern external beam radiotherapy devices are equipped with planar and/or 
volumetric X-ray imaging capabilities. Typically, a flat panel detector and X-ray 
generator are attached to the treatment machine allowing rotation of the beam 
around the patient. Alternatively, mega voltage (MV)-treatment beam with a flat 
panel detector can be used. 
To evaluate patient positioning accuracy, the use of sCT-based workflow is 
compared to standard CT-based positioning including both planar (publications 
I and III) and volumetric (publication III) registrations.  
Planar evaluation 
In the Digitally reconstructed radiograph (DRR) studies, 20 consecutive pa-
tients were included in both publication I and III. Manual registrations between 
CT-DRR and planar kV-radiograph were compared with the manual registra-
tions between sCT-DRR to planar kV-radiograph (see Figure 5 for visualization 
of performed registration workflow). The manual registrations were performed 
using a Matlab-based tool simulating the paired registration of planar kV- and 
DRR-images in two orthogonal directions simultaneously. The observers were 
asked to perform manual registrations of the paired projections shown to them 
in random order. 
Five observers registered the CT- and sCT-based DRRs to daily localization 
radiographs (kV-setup images) in both studies. Each image pair was evaluated 
three times by the same observer to obtain repeated measurements enabling the 
assessment of measurement quality in terms of inter- and intra-observer varia-
bility (publication II). In total, 300 (5 observers, 20 patients, 3 repetition) reg-
istration were performed per method in both publications. The assessment of 
positioning accuracy was performed by computing the mean and standard de-
viation (SD) of the difference of registrations obtained by CT-DRR and sCT-
DRR. 
Volumetric evaluation 
The cone beam computed tomography (CBCT) based verification of patient po-
sition was studied by comparing the registrations between CT to CBCT and sCT 
to CBCT relying on either bony structures or soft tissue contrast. In both regis-
tration methods, ten consecutive patients with a randomly chosen fraction were 
selected and the registration between the images were performed in the Offline 
Review module of Eclipse TPS (Varian Medical Systems Finland Oy, Helsinki, 
Finland). The performance of the bone-based registration was assessed as a dif-
ference between CT and sCT positioning. The observer was instructed to posi-
tion the patient using automatic registration tools prior to the treatment. Both 
PTV and OAR structures were visible during the registration.  
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In the evaluation of soft-tissue-based position verification, two datasets were 
prepared using patients with radical prostate cancer. The first set contained 
original CT, sCT and CBCT images, where the fiducial markers were visible in 
the images directly or as contours. In the second set, the markers were removed 
from CT, sCT and CBCT images using the Photoshop 6 (Adobe Inc., City of San 
José, CA, USA) image processing tool. Three evaluators performed registrations 
for both image sets (see Figure 5) and the difference between marker-based and 
soft tissue-based registration was used as the goodness metric of registration for 
both modalities independently. 
 
 Figure 5: Performed registrations in the patient positioning accuracy study for planar (left) and volu‐
metric (right) registrations. In the planar registration study, the sCT images were rigidly registered to 
the planning CT using bones, making the reference registration (R1). Both CT‐ and sCT‐based DRRs were 
registered to an orthogonal planar kV‐radiographs pair facilitating comparison between the registra‐
tions R2 and R3. In the volumetric registration study, bone‐based registration accuracy is evaluated by 
comparing R4 to R5 whereas, for the soft‐tissue based registration the difference R5‐R5’ and R4‐R4’ are 
compared. 
3.3 Geometric accuracy of magnetic resonance imaging 
In MRI, geometric distortions can arise from various sources. The most signifi-
cant sources of distortion result from the MR system itself and the patient being 
imaged [15,18] (see Table 2). In addition, MR-imaging related aspects, such as 
patient motion, can cause distortions. 
The inhomogeneity of the static magnetic field, B0, creates a spatial displace-
ment of the MR signal along the frequency encoding direction in the image 
plane, and along the slice selection direction in 2D imaging. The amplitudes of 
these distortions are related to the strength of the gradient fields along the fre-
quency and slice encoding directions, respectively [18].  
In addition, non-linearities in the gradient fields, Bgrad, translate into spatial 
displacements in all spatial directions. It has been shown that geometric distor-
tions related to the magnetic field B0 decrease with increasing gradient 
strength, while gradient-related distortions are virtually independent of the gra-
dient strength [18]. 
Patient induced field distortions result from large changes of magnetic sus-
ceptibility (such as air-tissue interfaces) within the patient [13,19]. These local 
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field distortions contribute to the total distortion like system induced B0-dis-
tortions. Unlike system related distortions, patient induced distortions vary 
from patient to patient making their correction more challenging.  
In this thesis, the most probable sources of geometric distortion were evalu-
ated using the workflows illustrated in Figure 6. 
 
 
 Figure 6: Workflow for analyzing both system (left) and patient (right) induced geometric distortions in 
MR‐images. System induce distortions were measured using a rigid 3D phantom containing MR‐positive 
markers. A distortion map is computed from discrepancies between known and measured marker po‐
sitions and the map is interpolated to the patient image grid to quantitate the patients contour distor‐
tions. Patient induced distortions were analyzed by obtaining an estimate of magnetic field distortion 
within the patient by mean of dual echo gradient echo image.  
3.3.1 MR-system induced geometric distortions 
Spatial displacement of the MR signal that originates from static field inho-
mogeneity and gradient non-linearity can, with 2D Fourier transformation im-
aging techniques be expressed as [18,20]: 
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 ∆𝑧ሺ𝑥, 𝑦, 𝑧ሻ ൌ ∆𝐵௚௥௔ௗ,௭ሺ𝑥, 𝑦, 𝑧ሻ𝐺௦௟௜௖௘ ൅
∆𝐵଴ሺ𝑥, 𝑦, 𝑧ሻ
𝐺௦௟௜௖௘  (1) 
  
 
 ∆𝑦ሺ𝑥, 𝑦, 𝑧ሻ ൌ ∆𝐵௚௥௔ௗ,௬ሺ𝑥, 𝑦, 𝑧ሻ𝐺௣௛௔௦௘  
 
(2) 
 
 ∆𝑥ሺ𝑥, 𝑦, 𝑧ሻ ൌ ∆𝑥ሺ𝑥, 𝑦, 𝑧ሻ𝐺௥௘௔ௗ ൅
∆𝐵଴ሺ𝑥, 𝑦, 𝑧ሻ
𝐺௥௘௔ௗ  
 
(3) 
with z = slice selection direction, y = phase encoding direction, and x = fre-
quency encode (readout) direction. 
Usually geometric accuracy of MRI-devices is tested using existing tools such 
as ACR (American College of Radiology) phantom. Unfortunately, the diameter 
of existing phantoms is not sufficient to cover the used FOV in radiotherapy use 
of MRI. Instead larger, more appropriate phantoms will be needed in MRI-only 
commissioning. 
In publications I and III, a large 3D phantom was used to measure the system-
induced geometric distortions arising from gradient field non-linearity and 
static magnetic field (B0) inhomogeneity. The 3D phantom consists of seven 
acrylic plates with inter-plate distances of 65 mm. Each plate contains 240 fidu-
cial markers placed in a regular grid with inter-fiducial distances of 25 mm. The 
phantom was scanned with a T1-weighted fast field echo (FFE) sequence [21] 
using the same MR scanner type that was used for the generation of the sCT 
images.  
The error as a function of the location inside the MR scanner was determined 
by comparing the fiducial locations to the known phantom grid. In order to as-
sess the impact of geometric distortions to RT, the 3D distortion map was inter-
polated to the individual patient’s sCT image grid. Using the obtained distortion 
map, the distortion of the patients PTV and OAR contours were analyzed (see 
Figure 6 illustration of the workflow). The analysis constituted of measuring the 
impact of geometric distortions to patient dose calculations. 
3.3.2 Patient induced geometric distortions 
Patient induced distortion was assessed in publication I by obtaining a ∆𝐵଴ 
field map for each patient using a dual echo gradient echo MR-image as sug-
gested by Baldwin et al. [22] and Stanescu et al. [23]. The phase images were 
unwrapped using an algorithm developed by Jenkinson et al. [24].  
The phase difference between the two images is used to compute a pixel-per-
pixel distortion map ∆𝐵଴ in units of millimeters as follows: 
 ∆𝐵଴ ൌ ∆థଶగ ∆்ா
∆௫
஻ெೣ, (4) 
where ∆𝜙 (radians) is the phase difference between two echoes acquired with 
phase difference of ∆𝑇𝐸 (s), ∆𝑥 is the pixel size (mm) and 𝐵𝑀௫ is the receiver 
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bandwidth (Hz per pixel) of the sequence being studied (see Figure 6 for illus-
tration of the workflow).  
Impact of patient induced distortions were analyzed by computing the histo-
gram voxel-by-voxel distortions. 
 
Table 2: Summary of main contributing factors to geometric distortions in MRI. 
3.3.3 Body outline differences between sCT/MRI and CT 
In addition to geometric distortion related to system and patient induced mag-
netic field distortions, the body outline can differ between CT and sCT because 
of other reasons. These include, for example, patient breathing motion and scan 
duration, being substantially longer in MRI compared to CT. 
The differences between body outlines in CT and sCT were evaluated as a func-
tion of angle from the treatment isocenter in publication III (for illustration of 
the analysis see Figure 7).  
 
 
Distortion Direction of 
distortion 
Where occurs? Mitigation Sequence de‐
pendent? 
Main field de‐
pendency 
Static B0‐field 
inhomogene‐
ity  
‐Frequency 
encoding 
‐ Slice selec‐
tion (only in 
2D imaging) 
Distortions increase 
with increasing dis‐
tance from isocenter 
‐Increase re‐
ceiver band‐
width 
-Use of thin 
slices in 2D 
imaging 
Yes Distortion 
scales linearly 
with field 
strength 
Patient in‐
duced static 
field inhomo‐
geneity 
‐Frequency 
encoding 
‐ Slice selec‐
tion 
Near large suscepti‐
bility differences 
Increase re‐
ceiver band‐
width 
Yes Distortion 
scales linearly 
with field 
strength 
Gradient non‐
linearity 
All direc‐
tions 
Distortions increase 
with increasing dis‐
tance from isocenter 
use 3D ge‐
ometry cor‐
rection 
No Independent of 
static field 
strength 
Eddy Currents  All direc‐
tions 
Usually very small, 
observable with DWI‐
EPI (causes time vary‐
ing inhomogeneity 
during signal readout) 
Increase re‐
ceiver band‐
width 
Yes, depends 
on gradient 
amplitude and 
slew rate (and 
receiver BW) 
Independent of 
static field 
strength 
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 Figure 7: Workflow for body outline difference evaluation. First the body outlines from CT and sCT are 
overlaid. Then the difference between the outlines are computed along a radial line originating from 
the treatment isocenter. Thus, the difference also reflects the body outline difference along the treat‐
ment beam path. The body outline differences from all patients are averaged at various craniocaudal 
distances from the isocenter for more condensed information. 
3.4 Acceptability of MRI-only workflow 
Use of sCT may potentially introduce both dosimetric and geometric inaccura-
cies. In addition, both sources of inaccuracies may contribute systematically 
and/or randomly to total treatment accuracy (see Table 3). 
When performing dosimetric or position verification evaluations for a sCT dis-
crepancies will be expected. For example, CT and sCT are taken during a sepa-
rate imaging session and, consequently, it is expected that similar dose or posi-
tioning accuracy variations apply that are present inter-fractionally. Thus, the 
introduced differences must not exceed the average difference that is observed 
between two fractions. In addition, the use of sCT should not introduce any ob-
servable systematic differences to dosimetric or geometric accuracy. 
Possible degradations of geometric accuracy in MRI-only workflow compared 
to the combined workflow of using CT with registered MR should be assessed 
by comparing to the reduction of systematic uncertainty of up to 2 mm [25] for 
not having to register CT and MR modalities [26]. 
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Table 3: Contribution of differences between CT and sCT to random and systematic dosimetric and ge‐
ometric accuracy and precision of MRI‐only treatments.  
Target of 
evaluation 
 Acceptance criteria Affects 
 
Dosimetric 
agreement 
systematic Total dosimetric accuracy should 
not exceed acceptance limit 
Under or over dosage of 
CTV and/or OARs. 
 random Keep below inter-fraction varia-
tion 
Under or over dosage of 
CTV and/or OARs. 
Positioning systematic Total geometric accuracy should 
not exceed acceptance limit 
Strongly affects likeli-
hood for geometric miss 
 random Keep below inter-fraction varia-
tion for used IGRT strategy 
Contributes to likelihood 
of geometric miss 
MR geomet-
ric accuracy 
systematic Total geometric accuracy should 
not exceed acceptance limit 
- Strongly affects likeli-
hood for geometric miss 
- Body outline distortion 
affects dose computation 
accuracy 
 
3.4.1 Achievable dosimetric accuracy 
Different tolerance levels for total accuracy requirement of RT have been pro-
posed in the literature in order to ensure adequate tumor control, converging 
towards a tolerance of 3.0-3.5% [27]. When eradication of the tumor is desira-
ble, an accuracy of 5% in delivered absorbed dose to the target volume has been 
recommended by ICRU [28].  
A way of quantifying the total uncertainty is to analyze the uncertainty in the 
different links in the radiotherapy treatment chain. In Table 4 up-to-date esti-
mates of uncertainties in modern RT process are presented. The figures are 
based on AAPM estimates [29] and more up-to-date estimates presented by 
IAEA [30]. 
 
Table 4: Estimates of uncertainty in modern RT (in terms of one standard deviation) in absolute dose 
in the patient for the complete treatment procedure using megavoltage photons. Uncertainty ex‐
pressed as one standard deviation (SD). 
Sources of Uncertainties  Uncertainty (%) 
Dose at the calibration point in water  1.5 
Additional uncertainty for other points 0.6
Beam Monitor stability  1.0
Beam flatness  1.5 
Patient data  1.5 
Patient set up and organ motion  2.5 
Dose calculation  2
   
TOTAL  4.2 
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3.4.2 Achievable geometric accuracy 
The geometric uncertainty cumulates from practically all steps required for the 
complete external beam workflow [10,31]. In Table 5 the sources of geometric 
uncertainties are presented and divided into uncertainties causing systematic 
and random error in the workflow of external beam radiation therapy. The reg-
istration uncertainty for a CT-to-MR registration for a prostate case was esti-
mated to be 2 mm based on current reports in scientific literature [25]. 
 
Table 5: Achievable geometric accuracy in external beam radiation therapy of pelvis using combined 
workflow utilizing CT for dose computation and MRI for target and OAR contouring. Uncertainty ex‐
pressed as one standard deviation (SD). The Planning target volume (PTV) margin is calculated as 
2.5*SE+0.7*RE, where SE is systematic error and RE is random error. 
 
Systematic error 
(mm) Random error (mm) 
Contributing factor RL AP CC RL AP CC 
Target delineation  1.8  1.8  2.8  0  0  0 
Target MR geometrical distortion  0.2  0.2  0.2  0  0  0 
MR to CT registration  2  2  2  0  0  0 
Total treatment planning uncertainty  2.7  2.7  3.4  0  0  0 
Intra‐fraction uncertainty  0  0  0  0.4  1.4  1.4 
DRR to X‐ray registration  0  0  0  0.5  0.5  0.1 
X‐ray imaging uncertainty  1  1  1  0  0  0 
Bone segmentation inaccuracy  0  0  0  0  0  0 
Total set‐up uncertainty  1  1  1  0.6  1.5  1.4 
   
Total  2.9  2.9  3.6  0.6  1.5  1.4 
             
Total systematic and random error  3.9  3.9  5.0  0.6  1.5  1.4 
PTV margin (mm)  7.6  8.2  10.0       
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4. Summary of results 
4.1 Dosimetric agreement 
Dosimetric accuracy of used sCT generation method was evaluated in publica-
tions I and III. 
The mean (SD) dose differences of the PTV mean dose computed over cancer 
groups, each with 15 patients, were less than 0.2 (0.4) % between sCTc and CT. 
The mean relative dose differences for studied volumes were less than 0.3 
(0.6)% for OARs (see the Table 6).  
 
Table 6: Mean (SD) dosimetric differences between sCT and CT‐based dose computations. Results 
from publication III.  
 
Pelvic 
lymph 
nodes 
(n=15) 
Rectal 
cancer 
(n=15) 
Gynecological 
cancer (n=15) 
Prostate can‐
cer, post‐op‐
erative (n=15)
Prostate can‐
cer, definitive 
(continuous 
HU, n=15) 
Prostate can‐
cer, definitive 
(bulk HU, n=15) 
DVH compari‐
son     
PTV     
Mean  0.0 (0.4)   0.1 (0.3)   ‐0.2 (0.4)   0.1 (0.3)   0.1 (0.2)  0.1 (0.2)  
D2%  0.1 (0.5  0.5 (0.6)   0.1 (0.4)  0.2 (0.6)  0.1 (0.2)  0.1 (0.2) 
D50%  0.0 (0.4)  0.1 (0.3)  ‐0.2 (0.4)  0.0 (0.3)  0.1 (0.2)  0.1 (0.2) 
D98%  ‐0.1 (0.3)  0.0 (0.4)  ‐0.2 (0.5)  0.0 (0.3)  0.1 (0.3)  0.1 (0.2) 
Rectum      
V95%  0.1 (0.3)  ‐  ‐0.2 (1.8)  0.1 (0.4)  0.1 (0.1)  0.1 (0.1) 
V75%  0.0 (0.1)  ‐  ‐0.3 (0.6)  0.0 (0.2)  0.0 (0.1)  0.0 (0.1) 
Bladder    
V95%  ‐0.1 (0.3)  0.1 (0.5)  ‐0.1 (0.9)  ‐0.1 (0.2)  0.0 (0.2)  0.0 (0.2) 
V75%  0.0 (0.2)  0.1 (0.2)  0.0 (0.2)  0.0 (0.1)  0.0 (0.1)  0.0 (0.1) 
Gamma statis‐
tics (V10%) 
           
2%/2mm  97.7 (0.7)  96.2 (2.0)  97.0 (1.5)  98.0 (0.6)  99.1 (0.5)  98.9 (0.4) 
Dose statistics 
per volume         
   
V10%  0.0 (0.2)  0.1 (0.3)  ‐0.1 (0.3)  ‐0.1 (0.2)   ‐0.1 (0.2)  ‐0.3 (0.2) 
The mean gamma-index pass-rate evaluation was highest for the prostate can-
cer patients and lowest for the gynecological and rectal cancer patients. Among 
all groups, the average pass-rates within volumes of V10% were higher than 95% 
with 2%/2mm gamma-criteria, respectively. The lowest pass-rate was for the 
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rectum cancer group being 96.2 (2.0) %. The mean relative dose differences 
were less than 0.3 (0.3) % for all studied cancer groups and volumes of interest.  
4.1.1 Acceptable dosimetric deviation 
In Table 7 the total uncertainty is estimated when the error from MRI-only 
based dose calculation is taken into account (see Table 4). Assuming a 2% un-
certainty in the calculation algorithm when used on CT data, an additional un-
certainty of 2.6% due to the MRI-only dose planning step fulfils the 5% dose 
accuracy criterion today.  
Table 7: Determination of the total uncertainty (in units of 1 SD) when MRI dose planning is intro‐
duced to the radiotherapy treatment chain. Based on the estimates in Table 4. 
Additional uncertainty inherent from 
MRI‐based dose planning (mm) 
Total Uncertainty (%) 
1  4.4 
2  4.7
3  5.2 
4.2 Positioning accuracy 
Positioning accuracy and precision were evaluated in publications II and III.  
4.2.1 Positioning based on planar images 
Using the bulk sCT method (sCTb) in publication I, mean (SD) differences be-
tween DRR-to-kV radiograph registrations were -0.5 (1.4), -0.1 (1.3) and 0.1 
(0.8) mm in AP, CC and LR directions, respectively. Whereas, with the sCT with 
continuous HU values (sCTc) in publication III, the differences were -0.1 (1.4), 
0.3 (1.2) and -0.1 (0.8) mm. Boxplot of the differences with both methods is 
illustrated in Figure 9. 
Typical digitally reconstructed radiographs from CT, sCTc and sCTb are illus-
trated in Figure 8. 
4.2.2 CBCT-based positioning 
For the bone-based positioning studied with ten patients, the mean (SD) ob-
server differences were 0.1 (1.1) mm, 0.1 (0.6) mm and -0.0 (0.2) mm in AP, CC 
and LR directions, respectively (see Figure 10). 
For the soft-tissue-based positioning in the AP direction, the mean (SD) dif-
ferences between fiducial markers- and soft-tissue-based registrations were 0.5 
(1.8) mm, 0.5 (1.8) mm and 1.1 (1.8) mm for CT, sCTc and sCTb, respectively. In 
the CC direction, the mean (SD) differences were -0.2 (1.1) mm, -0.6 (1.3) mm 
and -0.8 (2.3) mm, respectively. Furthermore, the smallest registration differ-
ences were seen in the LR direction, being 0.1 (0.7) mm, -0.4 (0.7) mm and -0.2 
(0.6) mm for CT, sCTc and sCTb, respectively. 
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 Figure 8: Example DRR images from Eclipse treatment planning system using bone rendering (HU values 
less than 100 and above 1000 omitted). CT (left), sCTc with continuous HU values (middle), and sCTb 
with discrete HU values, (right). 
 Figure 9: Boxplot of difference between CT‐DRR to planar kV‐image  in anteroposterior  (AP),  cranio‐
caudal (CC) and left‐right (LR) directions in publication I (left) and III (right). 
 Figure 10: Left: Box‐plot of registration difference between CT‐to‐CBCT and sCTb‐to‐CBCT using bone‐
based registration in left‐right (LR), anterior‐posterior (AP) and cranio‐caudal (CC) direction. Right: Box‐
plot of  registration differences between CT  to CBCT and sCT  to CBCT using soft‐tissue contrast with 
respect to marker‐based registration in AP, CC and LR directions. 
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4.2.3 Total spatial uncertainty between workflows 
Comparison of Table 5 and Table 8 shows that omission of the CT to MR co-
registration in the MRI-only workflow reduces the systematic uncertainty in the 
EBRT workflow of pelvis. In turn, according to our results, use of sCT for patient 
positioning may add both systematic and random geometric uncertainty result-
ing from increased DRR to X-ray image registration uncertainty.  However, the 
analysis showed that smaller margin of 6.9 vs. 7.6, 6.8 vs. 8.8 and 8.6 vs. 10 mm 
in right-left, anteroposterior and craniocaudal directions can be used in MRI-
only workflow vs. MR-fusion based workflow. Furthermore, in Publication II we 
showed that when registration errors are larger than 1.7 mm, 1.5 mm, and 1.1 
mm in AP, CC and LR directions, statistically significantly smaller CTV to PTV 
margin was needed in MRI-only workflow. 
 
Table 8: Achievable geometric accuracy in external beam radiation therapy of pelvis using MRI‐only 
workflow. Uncertainty expressed as one standard deviation (SD). The PTV margin is calculated as 
2.5*SE+0.7*RE, where SE is systematic error and RE is random error. 
 
sCT systematic error 
(mm) 
sCT random error 
(mm) 
Contributing factor RL AP CC RL AP CC 
Target delineation  1.8  1.8  2.8  0  0  0 
MR geometrical distortion  0.2  0.2  0.2  0  0  0 
MR to CT registration  0  0  0  0  0  0 
Total treatment planning uncertainty  1.8  1.8  2.8  0  0  0 
Intra‐fraction movement  0  0  0  0.4  1.4  1.4 
DRR to X‐ray registration 1  1  1  0.6  0.5  0.5  0.1 
X‐ray imaging uncertainty  1  1  1  0  0  0 
Total set‐up uncertainty  1.4  1.4  1.2  0.6  1.5  1.4 
   Total  2.3  2.3  3.0  0.6  1.5  1.4 
             
Total systematic and random error  2.9  2.9  4.1  0.6  1.5  1.4 
PTV margin (mm)  6.2  6.8  8.6 
4.3 Geometric accuracy 
Geometric accuracy of used sCT generation method was evaluated regarding 
system induced geometric distortions (publications I and III) and the contribu-
tion of patient induces distortion was assessed in publication I. 
4.3.1 System’s geometric accuracy 
Geometric fidelity of the MR images was assessed for all patients and PTVs in 
the ROIs consisting of the clinical RT planning structures.  
For all OAR structures, the distortion was measured to be less than 1 mm for 
all patients and PTVs (see illustration of the organ and disease specific figures 
 
1 Based on results from publication II, Figure 6 
Summary of results 
in Figure 11). Furthermore, the maximum distortion in the body outline at which 
the radiation beam enters the body was less than 2 mm for all prostate and rectal 
cancer patients. For one gynecological patient, the body outline distortion was 
greater than 2 mm in the cranial end of the PTV. However, it can be seen in the 
standard deviation of the body outline distortion that the distortion was less 
than 2 mm for most of the outline. 
 
 
Figure 11: Population mean (range) distortion per structure as a function of distance from the isocenter 
of the device along craniocaudal direction 
4.3.2 Patient-induced geometric distortions 
Patient-induced geometric distortions were studied in the pelvis anatomy for 
four patients. In Figure 12, an example of the magnitude of patient-induced dis-
tortion is given in axial plan near the isocenter of the MR device. Largest distor-
tions were found near tissue-air interfaces (around rectum and near body out-
line). The distortions were found to be less than the pixel size of 1 mm for all 
studied patients. 
 
 
 
 
 
 
 
 
 
 
 
 
4.3.3 Body outline distortions 
The body outline differences, and the MRI-system-induced geometric distortion 
were the smallest close to the isocenter of MRI device. Nearby the isocenter, the 
difference of body outline between CT and sCTc was 2 mm on average, but it 
increased farther away from the isocenter and reaches the average difference of 
6 mm at 150 mm (see Figure 13). The contribution of geometric distortion to the 
skin outline difference was less than 2 mm within the investigated volumes. 
Figure 12: Evaluation of patient induced geometric distortion was based on phase map. 
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The systematic difference between CT and sCTc body outlines was observed 
for various CC distances from the isocenter of MRI device (see Figure 14). The 
largest systematic differences were present toward the cranial end of the studied 
FOV at angles corresponding patient’s anterior direction (angle 0°). Towards 
the caudal end, systematic differences were not found, but the random uncer-
tainty increased. 
 
  
Figure 13: Mean absolute body outline difference (solid blue line) and mean+1SD (dash‐dotted line) 
between CT and sCT images. Mean body outline geometric distortion (dashed red line), mean +1SD 
(red dashed‐dotted) and max distortion (red dashed line) of the body outline due to geometric distor‐
tions of MR images as a function of (cranio‐caudal) distance from the isocenter of MRI device.   
Summary of results 
 
Figure 14: Body outline difference between CT and sCT images (CT ‐ sCT) for various cranio‐caudal po‐
sitions (at the distances from ‐100 (caudal‐end) to 150 mm (cranial‐end) from the isocenter of MRI de‐
vice) averaged over all 75 patients included in the study.  
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5. Discussion 
5.1 MRI-only for EBRT of pelvic malignancies 
MRI-only radiotherapy will eliminate the systematic registration errors intro-
duced when transferring MRI information to the CT. However, challenges con-
cerning the deficient information about electron or mass density, necessary for 
dose calculation and patient setup are introduced [26,32,33]. Thus, prior to clin-
ical use of MRI-only, all impacted aspects of the workflow need to be assessed 
thoroughly—a procedure called commissioning. 
The results described in this thesis has paved the way for the implementation 
of a clinical MRI-only radiotherapy workflow for pelvic malignancies. Specifi-
cally, the work was focused on: 
 
- Dosimetric accuracy of a commercial sCT method 
- Geometric accuracy of patient positioning in the MRI-only workflow 
- Geometric accuracy of MR images used for sCT generation 
5.1.1 Dosimetric agreement 
The dosimetric accuracy was assessed by comparing sCT- to CT-based dose 
computation. In publication III, the dosimetric differences between CT and 
sCTc were found to be small among all cancer groups. Considering mean (SD) 
gamma-index pass-rates of 98.0 (0.6)%, 96.2 (2.0)% and 96.5 (2.3)% using 
2%/2mm gamma-criteria and mean (SD) dose differences of -0.1 (0.2)%, 0.1 
(0.3)% and -0.1 (0.3)% for the prostate base, rectum and gynecological cancer 
patients, the dosimetric agreement was found to meet the clinical acceptance 
criteria. Maspero et al. [34] used a deep learning-based sCT approach and eva-
luated its applicability for pelvic cancer patients and obtained pass-rates that 
were in line with this study. In addition, Maspero et al. [4] evaluated the feasi-
bility of the same method used in this study (sCTb) for rectal cancer patients 
obtaining the mean gamma-index pass-rate of 95.2 (4.0)% and mean dose de-
viation of -0.3 (0.2)% of prescription dose. 
Our results from publications I and III and those by Maspero et al. [34] 
showed that the dosimetric agreement was decreased for rectum and gyneco-
logical cancer patients in comparison to prostate cancer patients. According to 
the body outline comparison between CT and sCT, the difference increases far-
ther away from the imaging isocenter along CC axis. However, this was unlikely 
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due to geometric distortion, which increases with growing distance from the iso-
center, but rather due to breathing and positioning differences between CT and 
MRI modalities. Thus, higher dosimetric disagreement for patients with longer 
PTVs in cranio-caudal (CC) direction might arise from these differences. It has 
been suggested by Persson et al. that systematic differences between body out-
lines on CT and MRI could be attributable muscle relaxation during longer scan 
time [8].  
Acceptability of dosimetric agreement 
According to our results, the mean dosimetric uncertainty resulting from the 
use of the sCT remained below 1% for all tumor groups and all patients (Table 2 
in Publication III). Thus, the impact to the total dosimetric uncertainty of the 
EBRT workflow remains on acceptable level (see Table 7). 
5.1.2 Patient positioning 
Positioning based on planar images 
In this study, we measured the accuracy of sCT DRR to planar kV-image reg-
istration for IGRT of pelvic EBRT by comparing to a CT DRR to kV-image reg-
istration. According to the results, average positioning differences were smaller 
than 0.5 mm in all directions, respectively. These figures are similar to what has 
been reported for DRR to kV registrations for sCTs based on manually con-
toured bone segmentations in a similar measurement setup [35]. 
Based on the results, given that there is an uncertainty associated with CT-to-
MR registration larger than 1.7 mm, 1.5 mm, and 1.1 mm in vertical, longitudinal 
and lateral direction, it’s likely that use of MRI-only has a positive effect to the 
total geometric accuracy. In the literature uncertainties of 2 mm have been re-
ported for prostate RT (Roberson et al [25]). Thus, we conclude that in terms of 
total geometric accuracy benefits of using sCT likely outweigh the small increase 
in sCT DRR-based positioning uncertainty.  
CBCT-based positioning 
The mean difference between bone-based positioning between CT to CBCT 
and sCT to CBCT was less than 0.2 mm in all directions. The result was in agree-
ment with earlier studies reporting sub-millimeter accuracy for the bulk HU 
version of the used sCT method [1,5].  
Here, for the first time the soft-tissue prostate positioning of a sCT method 
was evaluated by comparing it to the fiducial marker-based reference. No dif-
ferences in the performance between CT and sCTc were observed. However, for 
sCTb, the differences were slightly larger in the CC and AP directions but not in 
LR direction. Thus, no major difference in positioning performance was found 
between the methods.  
Like the planar evaluation, we conclude that the benefits of the use of sCT in 
term of total spatial uncertainty will out weight the small positioning error in-
troduced when sCT images are used for patient position verification. 
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5.1.3 Geometric accuracy 
According to the literature, the geometric accuracy of 2 mm in ROI and 1 mm in 
PTV is desired for MR-guided RT [15]. In addition, MR systems dedicated to 
radiotherapy would require geometric accuracy within 2 mm [36]. We found 
that for all the patients the system-induced geometrical distortion was less than 
1 mm for PTV and OAR volumes. In addition, the deformation of body contour 
was less than 2 mm for all except one gynecological patient, when considering 
only the area at which the radiation beam enters the body. In Figure 11, however, 
one can see that the geometric distortion of body outline increases rapidly in the 
periphery of analyzed volumes. This indicates that 30 cm FOV in the CC direc-
tion cannot be increased for larger PTVs without compromising the geometric 
accuracy.  
Patient-induced distortions in transversal plane were assessed in the vicinity 
of MR device’s isocenter for avoiding the contribution of system induced B0 in-
homogeneity. The largest distortions were found in air-tissue interfaces. The ac-
ceptable distortions were less than ± 0.5 mm for all studied patients being 
smaller than system related distortions. When optimizing MR-sequences to be 
used in RT planning, the receiver bandwidth must be set high enough to avoid 
distortions of up to several millimeters [23]. In agreement with our results, 
Adjeiwaah et al. [13] found that the magnitude of patient-induced susceptibility 
distortions to be larger compared with residual system distortions at all deline-
ated structures except the external contour. 
The overall geometric accuracy of the MR images was found to be acceptable 
for EBRT of the pelvic area radiotherapy. 
5.2 Uncertainties and limitations in this study 
A fundamental property of MRI-only strategies is that the dosimetric accuracy 
can’t be measured without comparing to CT-based dose computations. This re-
sults into laborious dose comparison in both commissioning of a new method 
and when a MRI-only solution or the MR-imaging is updated.  
It is common that evaluations of sCT methods are performed with a relatively 
small sample sizes and as a single center studies [32,33]. The sample sizes are 
limited as manual comparison is very laborious. The small sample size limits 
also the reliability of generalizability of our results. Unfortunately, inclusion of 
sample sizes required for covering the clinical variation of patients is not feasi-
ble with manual and laborious comparative analysis performed in this study. 
From the hospitals point of few the benefits of using MRI-only may be out 
weighted by the burden of performing the comparisons. Thus, more automated 
and standardized methods to establish and maintain dosimetric and geometric 
accuracy of MRI-only methods needs to be developed. 
Each sCT method is different in terms of segmentation of soft-tissue and 
bones. Thus, it is mandatory that all methods are commissioned using the clin-
ical workflow and local patient cohort at the site. Consequently, the results pre-
sented in this thesis may not apply for other sites and, especially, for other sCT 
generation methods. However, the results shall be interpreted as a reference for 
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the performance evaluations at other hospitals performing their own evalua-
tions of the method. 
Our evaluation of the MR-related distortion was limited to the MR image that 
was used for sCT generation. In addition, other MR-images are taken within the 
same imaging session and used for target and OAR contouring. The geometric 
accuracy may vary from sequence to sequence and the results obtained in this 
work will not cover other sequence types and acquisition parameters. For exam-
ple, echo planar imaging (EPI), used for, e.g. diffusion weighted imaging, pro-
duces order of magnitude larger distortions [22]. The current practice of char-
acterizing MR geometric distortions utilizing spatial accuracy phantoms alone 
may not be enough for an MRI-only radiotherapy workflow. Therefore, 
measures to mitigate patient induced susceptibility effects in clinical practice 
such as patient-specific correction algorithms are needed to complement exist-
ing distortion reduction methods, especially for EPI based imaging [13]. 
5.3 Challenges and outlook of MRI in RT 
A few hospitals have reported about clinical use of MRI-only [1,6,9]. Interest 
toward MRI-only is growing but there remain some important challenges that 
need to be addressed prior to wider clinical acceptance of MRI-only. 
Quality assurance (QA) plays an important role in radiation therapy by ensur-
ing the high accuracy requirements in delivery of treatments. When the role of 
MR imaging changes from auxiliary to primary, also the demands for the QA 
will become stricter. Even though there are some publications related to QA in 
MRI-only [37], it remains an area requiring further development and investiga-
tion. Especially, quality assurance of dosimetric accuracy for individual patients 
remains a challenge. Possible solutions for patient dosimetric QA is the use of 
the electronic portal imaging dosimetry (EPID) [38,39] or patient bulk anatom-
ical density maps [40].  
The typical scan duration of MRI-only simulation is around 20 minutes Tyks. 
It is evident that substantial organ motion may take place within the scanning 
session. The movement of soft-tissue between sequences, for example prostate 
or difference in bladder volume, could be mitigated by MR-positive markers [41] 
so that position of the prostate could be verified to be the same between images.  
5.4 Conclusions 
Pelvic cancer patients would benefit from the usage of sCT in terms of decreased 
total uncertainties in EBRT [34,42,43]. This study demonstrated dosimetric, 
positioning, and geometric accuracy of an sCT for the EBRT of pelvic cancers. 
This study covered several possible positioning workflows that have not been 
assessed previously. The results were relevant when aiming to extend the use of 
sCT method to pelvic cancer patients in general.   
We showed that the dosimetric, geometric and positioning accuracy is enough 
for clinical use of the method investigated.
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ABSTRACT
Background: The clinical feasibility of using pseudo-computed tomography (pCT) images derived from
magnetic resonance (MR) images for external bean radiation therapy (EBRT) planning for prostate can-
cer patients has been well demonstrated. This paper investigates the feasibility of applying an MR-
derived, pCT planning approach to additional types of cancer in the pelvis.
Material and methods: Fifteen patients (five prostate cancer patients, five rectal cancer patients, and
five gynecological cancer patients) receiving EBRT at Turku University Hospital (Turku, Finland) were
included in the study. Images from an MRCAT (Magnetic Resonance for Calculating ATtenuation,
Philips, Vantaa, Finland) pCT method were generated as a part of a clinical MR-simulation procedure.
Dose calculation accuracy was assessed by comparing the pCT-based calculation with a CT-based cal-
culation. In addition, the degree of geometric accuracy was studied.
Results: The median relative difference of PTV mean dose between CT and pCT images was within
0.8% for all tumor types. When assessing the tumor site-specific accuracy, the median [range] relative
dose differences to the PTV mean were 0.7 [0.11;1.05]% for the prostate cases, 0.3 [0.25;0.57]% for
the rectal cases, and 0.09 [0.69;0.25]% for the gynecological cancer cases. System-induced geometric
distortion was measured to be less than 1mm for all PTV volumes and the effect on the PTV median
dose was less than 0.1%.
Conclusions: According to the comparison, using pCT for clinical EBRT planning and dose calculation
in the three investigated types of pelvic cancers is feasible. Further studies are required to demonstrate
the applicability to a larger cohort of patients.
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Introduction
Computed tomography (CT) is currently the primary imaging
modality for providing anatomical and tissue density informa-
tion for external beam radiation therapy (EBRT) planning of
prostate, rectal, and gynecological cancers. Magnetic reson-
ance imaging (MRI) is widely used as a supplement to CT
imaging in the planning of EBRT for pelvic cancers. The major
advantages of MRI over CT are primarily better soft tissue
contrast, which results in more accurate gross tumor volume
(GTV) and organ at risk (OAR) delineation, lower inter-obser-
ver variability, better organ at risk (OAR) visibility, and better
regional lymph node characterization [1]. Additional benefits
include the usage of non-ionizing radiation and the versatility
of existing imaging methods for cancer type or organ specific
imaging methods [1].
A major drawback of multi-modality imaging in radiation
therapy (RT) is the registration errors introduced when
images from two or more imaging modalities are registered
and fused [2]. Recent advances in the use of MRI in RT prom-
ise to eliminate this registration error by using only MR
images for planning and dose calculation in EBRT of prostate
[3–7] and brain [8,9]. In an MR-only workflow, the so-called
pseudo-CT images are generated from the MR images, pro-
viding tissue density information for dose calculation and ref-
erence images for patient position verification at the linear
accelerator. However, despite the benefits of MR-based RT
planning, it has not been investigated if it is possible to use
existing pseudo-CT methods for other cancer types in the
pelvic anatomy [1,10,11]. The pseudo-CT methods suitable
for prostate may not be directly applicable to other pelvic
targets due to the larger treatment volumes that are charac-
teristic of pelvic tumors in general.
The geometric accuracy of images used in RT directly
affects the required treatment margins and treatment out-
comes of EBRT [12]. Consequently, geometric accuracy of MRI
has been studied in several publications and also reviewed
recently [12]. However, a major limitation of previous studies
has been that they only consider volumes relevant for a
dual-modality workflow, whereby MR-images are registered
to a planning CT. The accuracy of the full body contour is
relevant in the context of an MR-only workflow due to its dir-
ect impact on dose calculation accuracy. Thus, we find it
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important to study the effect of geometric distortions on
dose calculation accuracy, especially for the large PTV vol-
umes typically treated in pelvic cancers.
The aim of this study was to evaluate the feasibility of an
existing MR-only method in terms of dose calculation and
geometric accuracy in EBRT for the pelvic area in general.
The method is singularly used for prostate cancer, presently
the only indication included in the labeling of this method.
Since large target volumes are typically treated in gyneco-
logical and rectal cancer patients, both system-related geo-
metric distortion and patient-induced distortion were
evaluated in the pelvic anatomy in order to quantify their
impact on the dose planning and calculation accuracy.
Material and methods
Study design and image acquisition
The study cohort consisted of 15 consecutive pelvic cancer
patients (five prostate, five rectal, and five gynecological)
treated with EBRT at the Department of Oncology and
Radiotherapy of Turku University Hospital in Turku, Finland. The
mean (±SD) age was 74.3 (±4.8), 69.2 (±12.8), and 72.8 (±8.3)
years and mean (±SD) weight was 91.4 (±21.7), 73.8 (±8.6), and
74.4 (±18.3) kg for the prostate, rectal, and gynecological
groups, respectively. In the prostate cancer group, the PTV (vol-
ume mean (±SD) was 410 (±520) cm3) included prostate, sem-
inal vesicles and, for two patients, extra capsular tumor
extension was detected from the MR-images. For the rectal can-
cer group, the PTV (volume mean (±SD) was 1530 (±410) cm3)
was contoured according to clinical practice for preoperative
EBRT of rectal cancer. For three out of the five gynecological
patients, the PTV (volume mean (±SD) was 1910 (±990) cm3)
included the primary tumor, the regional lymph nodes and,
when applicable, other likely volumes of spread disease.
In pelvic cancer, GTVs, including both the primary tumor
and involved lymph nodes, were delineated in the MR
images, and CTV was created by adding 5–15mm to GTVs in
order to include subclinical or microscopic extensions of the
disease. CTV also included regional lymph nodes at high risk
for the spreading of microscopic cancer. PTV was then cre-
ated by adding 10–15mm margins to CTV. PTV determina-
tions were performed according to international guidelines
on treating prostate, rectal, or gynecological cancer. Two
gynecological and one prostate cancer patient received post-
operative RT, and for those patients, a postoperative tumor
bed was included in the CTV. The time in between the CT
and the MR simulations was less than 1 d for all patients.
The manufacturer’s 3D gradient non-linearity correction algo-
rithm was used in all the MR images.
CT simulation images were acquired using an Aquilion LB
(Toshiba Corp., Tokyo, Japan) scanner with 2-mm-thick slices,
1 1mm2 in-plane resolution, and 120 kV tube voltage. MR
images were recorded with the Ingenia 1.5T HP (Philips
Medical Systems International B.V., Best, Eindhoven, The
Netherlands) scanner. For all patients, a transaxial T1-
weighted three-dimensional (3D) mDIXON sequence [13]
(a resolution of 1.04 1.04 2.50mm3) covering the full
body contour was acquired and used as a source for MRCAT
(Magnetic Resonance for Calculating ATtenuation, Philips,
Vantaa, Finland) images. The MR imaging time was less than
200 s for all patients, who were positioned similarly during
the imaging for CT and MR simulation. In the MR scan,
patients were placed in a supine position on a flat RT couch
top and an anterior MR-coil was placed above the imaging
volume using a coil holder provided by the manufacturer.
MRCAT pseudo-CT generation
In the pCT generating algorithm, CT-like density maps were
computed from the mDIXON MR-images in a two-step
approach (see online Supplementary material for more
detailed description of pCT generation). In the first step, the
content of the MR image was categorized into five classes. In
the second step, each voxel was assigned the following HU
values: air (968 HU), fat (86 HU), water-rich tissue (42 HU),
spongy bone (198 HU), and compact bone (949 HU). The
densities used for dose calculation were then obtained from
tabulated calibration values provided by the manufacturer
and were based on the combination of average population
values and values cited in the literature [14].
RT treatment planning and image processing
Pinnacle3 (version 9.10. Philips Medical Systems Inc., Fitchburg,
WI, USA) treatment planning system (TPS) was used for gener-
ating and calculating the plans for this study. All clinical plans
were originally done in Eclipse (version 13.6, Varian Medical
Systems Oy, Helsinki, Finland) TPS and exported to Pinnacle3,
where the clinical plans were re-optimized using the original
contours and a volumetric modulated arc therapy (VMAT) tech-
nique with two arcs. Planning was performed first using pCT
images and clinical contours. The plans were then copied to
the planning CT-image using identical planning parameters.
The copied plan was recalculated based on the CT image in
Pinnacle3 TPS using an adaptive convolution algorithm. The
CT-to-density calibration curve was based on a recent calibra-
tion with the RMI 465 (Gammex Inc., Middleton, WI) phantom.
The pCT-specific calibration curve provided by the manufac-
turer was used for pCT-based calculations.
In order to avoid confounding factors in dose comparison,
the original CT was first deformable registered to the pCT
source image (called CT_DIR) using Mirada (Mirada Medical
Ltd., Oxford, UK) medical imaging software. The deformable
registration was required since differences in the body outline
would have otherwise caused dose differences that were not
related to the performance of the pCT. Furthermore, it allows
compensation of bladder and rectum filling differences and
inner organ movement. An example of deformable registration
can be seen in Figure S2 in the online Supplementary material.
The deformable image registration may bias the dose
comparison results since MRI-related geometric distortions
are not taken into account due to the body outline matching
between pCT and CT images [12,15]. Furthermore, geometric
inaccuracies may take place also in PTVs and OARs further
away from the isocentre of the MR. In order to assess the
impact of the MR-system’s geometric accuracy on RT
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planning, another plan (called CT_DIR_C) where all structures
were corrected according to measured system’s geometric
distortion was created (see below for a description of distor-
tion measurement). This allowed the dose calculation dis-
crepancies originating purely from the geometric
inaccuracies to be studied independently from other sources,
such as density differences.
Evaluation of dose calculation accuracy
Dose volume histogram (DVH) curves and gamma differences
were analyzed for any changes between pCT- and CT-based
plans. Relevant PTV’s DVH-metrics were selected to reflect the
near maximum (D2%) and near minimum (D98%) values. For the
OARs investigated in this study, i.e., rectum and bladder, the
DVH-comparison dose of D35% was tabulated. In addition, the
differences in the median of mean doses to PTVs and OARs
were calculated. In order to investigate the impact of tumor
type to pCT performance, statistical analysis was performed to
assess the significance of the differences between the prostate
groups and the other two groups. The rationale for the statis-
tical analysis is that the performance of pCT has been demon-
strated for prostate EBRT and if no significant differences are
found in the comparison to rectal and gynecological targets,
such result would indicate clinical feasibility.
In addition to DVH comparison, the dose distributions
between pCT and planning CT were compared by means of
3D gamma analysis using VeriSoft (version 6.1, PTW-Freiburg,
Freiburg, Germany) treatment plan verification software.
Doses below 30% of the maximum dose in the calculated
volume were excluded from the analysis. The statistical tests
were performed to determine if there is a significant differ-
ence between clinical pCT for prostate and pCT for the other
pelvic areas (rectal and gynecological cancers).
All dose differences are given as relative differences between
the CT-based and pCT-based plans that can be formulated as
(pCT-CT)/CT. Thus, positive values indicate dose deficiency if the
treatment and dose calculation were based on pCT.
Assessment of geometric fidelity
Geometric distortions can be caused by both the MR system
and the patient [12]. In this study, a large 3D phantom was
used to measure the system-induced geometric distortions
arising from gradient field non-linearity and static magnetic
field (B0) inhomogeneity. In addition, patient-induced geo-
metric distortion was assessed by calculating a B0 inhomo-
geneity map from two-phase images of a dual-echo fast
field-echo (FFE) image as suggested by Baldwin et al. [17]
and Stanescu et al. [18]. The imaging parameters were as fol-
lows: TE1 of 1ms, TE2 of 5.6ms, TR of 6.8ms, slice thickness
of 4mm, and pixel size of 1 1mm2. Since the measured dis-
tortion originates from both the patient and the system, the
patient-induced distortion was assessed in the neighborhood
of the MR system’s isocentre, where system-related B0
inhomogeneity was the smallest. The phase images were
unwrapped using an algorithm developed by Jenkinson et al.
[19]. For the patient-induced distortion assessment, the
additional dual-echo scan was included to the hospital’s clin-
ical MR protocol for a group of four patients.
The large FOV-3D phantom consists of seven acrylic plates
with inter-plate distances of 65mm. Each plate contains
240 fiducial markers placed in a regular grid with inter-
fiducial distances of 25mm. The phantom was scanned with a
T1-weighted FFE sequence using the same MR scanner type
that was used for the generation of the pCT images. The imag-
ing parameters were as follows: a FOV of 560 560 400mm3,
an acquisition voxel size of 1.5 1.5 2.0mm3, a TE/TR of 3.4/
6.7ms, and a water–fat shift of 0.5mm. The error as a func-
tion of the location inside the MR scanner was determined
by comparing the fiducial locations to the known phantom
grid. In order to assess the impact of geometric distortions
to RT, the 3D distortion map was interpolated to the CT
image grid of the individual patients. The distortion map
was then used for the geometric correction of the RT struc-
tures. The corrected structures were created as DICOM RT
structure sets using MATLAB (version R2016b, The
MathWorks Inc., Natick, MA, USA) mathematical computing
software and imported to Pinnacle3 TPS for dose calculation.
The original CT_DIR plan was copied (the new plan is called
CT_DIR_C) and the structures were replaced with the geo-
metrically corrected structures. Finally, the impact on dose
calculation was simulated by using the density override in
Pinnacle, so that volume outside the distortion-corrected
body outline was assigned as air and the volume inside the
corrected outline was assigned as water for voxels for which
there was air in the uncorrected image.
Statistical analysis
Statistical analysis was conducted using Minitab (version 17,
Minitab Inc., State College, PA, USA) numerical analysis soft-
ware. The data were analyzed for statistical difference with
the non-parametric Mann–Whitney U test. This test was
chosen due to the fact that the same data were not used for
both treatment options and normality could not be guaran-
teed. For the statistical difference, 95% confidence level was
required (p< 0.05).
Results
Dose comparison
The mean (± SD) relative dose difference in PTV mean dose
computed over all 15 patients was 0.2 (± 0.5)% and the
median of relevant PTV DVH-points was less than 0.9% for all
studied tumor types, indicating good agreement between
pCT and planning CT in terms of dose calculation accuracy.
For the studied OARs, the median relative differences were
less than 1.2% (see Table 1).
The gamma pass rates were high for all studied PTVs and
pass criteria. The median pass rate was the highest for the
prostate patients and the lowest for gynecological patients.
Although the differences between groups were small, statis-
tically significant differences to the prostate group were
found for the gamma criteria of 2%/1mm in both the rectal
and the gynecological groups. In addition, there was a
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significant difference in the gynecological group when 2%/
2mm pass criteria were used. The results of the gamma ana-
lysis are shown in Table 2.
System’s geometric accuracy
Geometric fidelity of the MR images was assessed for all
patients and PTVs in the ROIs consisting of the clinical RT
planning structures. An example of the analysis is illustrated
in Figure 1, which demonstrates the contour distortions and
ranges (minimum to maximum) and contours of the distor-
tion map as a function of distance from the isocentre of the
MR device for the gynecological cancer patient that had the
largest PTV in the cranial–caudal direction.
For all OAR structures, the distortion was measured to be
less than 1mm for all patients and PTVs (see illustration of the
organ and disease specific figures in Figure 2). Furthermore,
the maximum distortion in the body outline at which the radi-
ation beam enters the body was less than 2mm for all pros-
tate and rectal cancer patients. For one gynecological patient,
the body outline distortion was greater than 2mm in the cra-
nial end of the PTV. However, it can be seen in the standard
deviation of the body outline distortion that the distortion
was less than 2mm for the majority of the outline.
Impact of geometric distortion to dose calculation
accuracy
According to the results, the impact on dose calculation
accuracy due to geometric distortions of the MR images
was small. The changes in the PTV DVHs were negligible, the
relative difference being less than 0.2% for all studied DVH
points (see Table 3). The gamma analysis was in line with the
DVH-based analysis: pass rate was highest for prostate cancer
patients and lowest for gynecological cancer patients (see
Table S1 in the Supplementary material). The median pass
rates were significantly different between prostate and gyne-
cological patients.
Patient-induced geometric distortions
Patient-induced geometric distortions were studied in the
pelvis anatomy for four patients. In Figure 3, an example of
the magnitude of patient-induced distortion is given in axial
plan near the isocentre of the MR device. Largest distortions
were found near tissue–air interfaces (around rectum and
near body outline). The distortions were found to be less
than the pixel size of 1mm for all studied patients.
Discussion
This work aimed at demonstrating the feasibility of using
MRCAT pCT for the RT of pelvic cancers in terms of dosimet-
ric and geometric accuracy. Our results show that the calcula-
tion accuracy is similar to reported in the literature. For
example, Korhonen et al. [3] have reported D50% to be 0.3
(± 0.2)% for prostate EBRT, and we obtained 0.6 (± 0.5)%, 0.2
(± 0.4)%, and 0.2 (± 0.5)% for prostate, rectal, and gyneco-
logical tumor patients, respectively. Furthermore, Siversson
et al. [4] have reported mean relative difference of 0.0
(±0.2)% and Kim et al. [5] 0.5% for PTV for EBRT of prostate.
However, they are not fully comparable since in the reported
studies the same CT scanner, calibration, and dose calcula-
tion are used for both pseudo-CT method’s development and
its validation, and thus this may provide by far too optimistic
results. Although no statistical significance was found
between prostate and other cancers, the difference in DVH-
points was almost significant and due to low power of the
test (small sample size and heterogeneous demographics),
the conclusions of similarity cannot be strongly considered.
Gamma analysis comparing the dose distributions of pCT
and the reference planning-CT showed clinically acceptable
pass rate for all cancer groups. The gamma pass rates (1%/
Table 2. Results of gamma analysis (median pass rate (min;max). Statistical tests were performed for equivalent median between
prostate and rectal or gynecological group, p< 0.05 indicating statistically significant difference.
Prostate Rectal Gynecological
Gamma criteria
1%/1mm 99.2 (93.8;100) 97.4 (96.4;99.0), p> 0.10 97.3 (94.3;98.9), p> 0.10
2%/1mm 100 (99.5;100) 99.0 (98.7;99.8), p¼ 0.03 98.5 (98.1;99.6), p¼ 0.02
2%/2mm 100 (99.8;100) 99.3 (99.1;100), p¼ 0.06 99.2 (98.9;99.8), p¼ 0.01
Table 1. Median (min;max) relative difference (%) between MRCAT and CT_DIR-based plans for relevant dose volume histogram
(DVH)-points and mean dose. Statistical tests were performed for equivalent median between prostate and rectal or gynecological
group, p< 0.05 indicating statistically significant difference.
Prostate Rectal Gynecological
PTV
Mean 0.73 (0.11;1.05) 0.30 (0.25;0.57), p¼ 0.09 0.09 (0.69;0.25), p¼ 0.06
D2% 0.70 (0.53;0.46) 0.08 (0.67;0.48), p> 0.10 0.20 (–1.23;0–06), p¼ 0.04
D50% 0.56 (0.11;1.04) 0.26 (0.26;0.54), p> 0.10 0.10 (0.65;0.20), p¼ 0.06
D98% 0.87 (0.11;1.42) 0.57 (0.09;1.02), p> 0.10 0.22 (0.51;0.72), p> 0.10
Rectum (OAR)
Mean 0.23 (0.19;1.25) [N/A] 0.14 (–1.10;0.23), p> 0.10
D35% 0.45 (0.63;1.78) [N/A] 0.19 (–1.00;0.62), p> 0.10
Bladder (OAR)
Mean 0.17 (0.79;0.64) 0.20 (0.25;0.43), p> 0.10 0.45 (0.75;0.13), p> 0.10
D35% –1.19 (–1.41;0.73) 0.24 (0.42;0.56), p> 0.10 0.24 (0.65;0.02), p> 0.10
PTV: planning target volume; OAR: organ at risk.
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1mm criteria) of 97.9%, 97.5%, and 96.9% for prostate, rectal,
and gynecological groups, respectively, were well in line with
results reported in the literature. Korhonen et al. [3] have
reported a gamma pass rate of 95.7% and Kim et al. [5]
97.2% between pseudo-CT and planning-CT doses evaluated
using the criteria of 1%/1mm for EBRT of prostate cancer.
According to the literature, the geometric accuracy of
2mm in ROI and 1mm in PTV is desired for MR-guided RT
[12]. We found that for all the patients the system-induced
geometrical distortion was less than 1mm for PTV and OAR
volumes. In addition, the deformation of body contour was
less than 2mm for all except one gynecological patient,
when considering only the area at which the radiation beam
enters the body. The impact of the body outline, PTV, and
OAR distortions on dose calculation accuracy was found to
be clinically insignificant, the mean relative difference of
0.2% being largest among all studied cancer groups. In
Figure 2, however, one can see that the geometric distortion
of body outline increases rapidly in the periphery of analyzed
volumes. This indicates that 30-cm-FOV in the cranial–caudal
direction cannot be increased for larger PTVs without com-
promising the geometric accuracy.
Patient-induced distortions in transversal plane were
assessed in the vicinity of MR device’s isocentre for avoiding
the contribution of system-induced B0 inhomogeneity. The
largest distortions were found in air–tissue interfaces. The
acceptable distortions were less than ±0.5mm for all studied
patients being smaller than system-related distortions. When
optimizing MR-sequences to be used in RT planning, the
receiver bandwidth must be set high enough to avoid distor-
tions of up to several millimeters [17,18]. Patient-induced
geometric distortion originating from the susceptibility differ-
ences has been studied by Stanescu et al. [18]. For 1.5T sys-
tem, the maximum distortion was 0.3mm when a gradient
strength of 20mT/m was used. Since pCT source scan uses
gradient strength of approximately 10mT/m, results are in
agreement with the values reported in the literature.
The system-induced geometric distortions are scanner
dependent, and thus the results apply only to the scanner type
and field strength used in this study. Additionally, the patient-
induced distortions are sequence dependent and apply only for
the studied sequences. Used 3D phantom for measuring the
residual distortions after gradient non-linearity correction was
considered as an object of known geometry. Therefore, the
measures of geometric distortion may be overestimated due to
any deviation from the assumed geometry which is not taken
into account in the analysis. Deviations in the phantom geom-
etry could be included into the analysis by using a CT scanner to
obtain a geometrically accurate reference image. In our analysis,
the measured residual geometric distortion consists of system-
Figure 1. An example of geometric distortion for a patient receiving external beam radiation therapy (EBRT) for cervical cancer. Above: mean and range of distor-
tion for the body (dashed), planning target volume (PTV) (dash-dotted), and organs at risk (OAR) (solid¼ bladder and dotted¼ rectum) as a function of distance
from the magnet’s isocentre along cranial–caudal direction. Below: illustration of the same plan in transversal (left: at the isocentre, middle 132mm away from the
isocentre) and coronal (right) planes with clinical structures and distortion contours of 1mm (inner) and 2mm (outer).
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related gradient and B0 distortions. In addition, the measured
sequence dependent geometric distortion is a measure of both
system and patient-induced B0 distortions. Thus, the system-
related B0 distortions are measured in both the phantom and
the patient experiments and their summation would double the
impact of distortions originating from the main magnet. Our
method can be considered adequate, since the scope of this
study was the assessment of clinical feasibility of using MRCAT
pCT for RT of pelvic cancers, rather than providing a quantitative
information of geometric distortions.
Currently, the cranial–caudal FOV of pCT image is limited
to 300mm that restricts its application in RT of wider pelvic
cancers. Consequently, without increasing the imaging vol-
ume, the pCT can be used for RT treatment planning of pri-
mary pelvic cancers together with the regional lymph
nodes, whereas it is not feasible for PTVs including para-
aortic lymph nodes. At Turku University Hospital, around
10% of the PTVs for treating gynecological cancer require
larger a FOV than that is possible to calculate by way of
the pCT method. Still, it would be feasible to treat the
majority of pelvic cancers and overall prostate, rectal and
gynecological RT treatments constituted 36%, 10%, and 13%
of all EBRT patients. The use of pCT in our clinic would
enable MR-only simulation for around 60% of the patients
being scanned with MR for RT.
The patient positioning at treatment device is based either on
bone registration using orthogonal X-ray images and digitally
reconstructed radiographs or on registration of the cone-beam
CT and the planning CT. When pCT is used, only two soft-tissue
HU-values are used, and thus the registration to the planning
imagemay not be feasible. Robust registrationmight depend on
continuous HU values for soft tissue [18,20]. The verification of
pCT-based patient positioning requires further studies before its
feasibility canbe stated.
Increasing the FOV in the cranio-caudal direction remains a
challenge in MRI since the geometric accuracy decreases rap-
idly farther away from the MR device’s isocentre. Furthermore,
motion blurring influenced by breathing in the abdomen
causes artifacts in the mDIXON image, which may hamper
accurate body outline detection. Recent development of MR
sequences may address some of the above-mentioned chal-
lenges in the near future. Several academic institutions and
industry are pursuing the technical advances aimed at in this
issue, so it is very probable that over the next few years some
solutions will be made commercially available, thus enabling
easier utilization of the method on-site [21].
Judging by the results of this work, we conclude that
the use of only four tissue classes is adequate to capture
individual variance in body composition and to produce
clinically acceptable accuracy in dose calculation for pros-
tate, rectal and gynecological cancer patients treated with
EBRT. In addition, the geometric accuracy of the MR sys-
tem used in the study was found to be sufficient for
larger PTV, which is a necessity in an MR-only application
for the pelvic area in general. Further studies are required
to assess the feasibility of soft-tissue or bone-based patient
positioning with pCT and to confirm our findings with a
larger cohort of patients.
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Figure 2. Population mean (± range) distortion per structure as a function of
distance from the isocentre of the device along cranial–caudal direction.
Dashed¼ body outline, dash-dotted¼ planning target volume (PTV), dot-
ted¼ rectum and solid¼ bladder. For the body structure, the mean ±1 SD is
also given (see the darker area around the mean values). PTV: planning target
volume; SD: standard deviation.
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D50% 0.10 (0.07;0.11) 0.07 (0.05;0.08), p¼ 0.04 0.09 (0.05;0.09), p> 0.10
D98% 0.12 (0.04;0.22) 0.10 (0.09;0.12), p> 0.10 0.09 (0.14;0.12), p> 0.10
Rectum (OAR)
Mean 0.51 (1.02; 0.1) – 0.02 (0.18;0.08), p> 0.10
V35% 0.69 (1.32;0.06) – 0.04 (0.29;0.07), p> 0.10
Bladder (OAR)
Mean 0.01 (0.12;0.09) 0.00 (0.17;0.02), p> 0.10 0.01 (0.04;0.07), p> 0.10
V35% 0.07 (0.18;0.08) 0.04 (0.36;0.07), p> 0.10 0.07 (0.03;0.09), p¼ 0.06
PTV: planning target volume; OAR: organ at risk.
Figure 3. An example of distortion map with color bar showing the amount of distortion (left), histogram of the error around the magnet isocentre (middle) for
the example on top and histogram of geometric distortion for all four patients included to the analysis (right).
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Introduction
In contemporary external beam radiation therapy (EBRT) of prostate cancer, computed tomography (CT) is the 
primary imaging modality providing anatomical and tissue density information. Magnetic resonance imaging 
(MRI) is widely used as a supplement to CT in EBRT of prostate cancer. The major advantages of MRI over 
CT are superior contrast-to-noise ration and better soft tissue differentiation resulting decreased contouring 
variability for prostate (Debois et al 1999) and reduced organs at risk (OAR) dose (Rasch et al 1999). Additional 
benefits include lack of ionizing radiation and versatility of existing MR imaging methods.
Major drawback of multi modal imaging in radiation therapy (RT) is the registration error introduced when 
images from two or more imaging modalities are registered (Nyholm et al 2009). Recent advances in usage of 
MR in RT promise to eliminate the registration error completely by using only MR images for EBRT planning of 
prostate cancer (Dowling et al 2012, Korhonen et al 2014, Kim et al 2015, Siversson et al 2015). In the MR-only 
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Abstract
Background and Purpose. Magnetic resonance imaging (MRI) has in recent years emerged as 
an imaging modality to drive precise contouring of targets and organs at risk in external beam 
radiation therapy. Moreover, recent advances in MRI enable treatment of cancer without computed 
tomography (CT) simulation. A commercially available MR-only solution, MRCAT, offers a 
single-modality approach that provides density information for dose calculation and generation of 
positioning reference images. We evaluated the accuracy of patient positioning based on MRCAT 
digitally reconstructed radiographs (DRRs) by comparing to standard CT based workflow. Materials 
and Methods. Twenty consecutive prostate cancer patients being treated with external beam radiation 
therapy were included in the study. DRRs were generated for each patient based on the planning CT 
and MRCAT. The accuracy assessment was performed by manually registering the DRR images to 
planar kV setup images using bony landmarks. A Bayesian linear mixed effects model was used to 
separate systematic and random components (inter- and intra-observer variation) in the assessment. 
In addition, method agreement was assessed using a Bland–Altman analysis. Results. The systematic 
difference between MRCAT and CT based patient positioning, averaged over the study population, 
were found to be (mean [95% CI])  −0.49 [−0.85 to  −0.13] mm, 0.11 [−0.33 to  +0.57] mm 
and  −0.05 [−0.23 to  +0.36] mm in vertical, longitudinal and lateral directions, respectively. The 
increases in total random uncertainty were estimated to be below 0.5 mm for all directions, when 
using MR-only workflow instead of CT. Conclusions. The MRCAT pseudo-CT method provides 
clinically acceptable accuracy and precision for patient positioning for pelvic radiation therapy based 
on planar DRR images. Furthermore, due to the reduction of geometric uncertainty, compared to 
dual-modality workflow, the approach is likely to improve the total geometric accuracy of pelvic 
radiation therapy.
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approach a so called pseudo-CT is obtained based on information available in the MR image. The pseudo-CT 
is then used to replace the CT image for both dose calculation and generation of digitally reconstructed radio-
graphs (DRRs). Generation of DRRs based on MR images will be required if the patient alignment prior to treat-
ment delivery must be verified by on-board planar x-ray imaging (Karlsson et al 2009).
Numerous studies have been published recently that report adequate dose calculation accuracy with differ-
ent MR-only strategies (Edmund and Nyholm 2017). The focus in MR-only publications has been in dosimetric 
accuracy and, albeit equally important for total accuracy and treatment outcome, less attention has been paid to 
complete workflow and geometric accuracy of suggested methods. Prior work has demonstrated that manually 
delineated pelvic bones can provide sufficient accuracy for patient positioning based on DRR images using bulk 
assignment of HU values for bones in an MR-only workflow (Chen et al 2007, Korhonen et al 2015). However, 
feasibility of positioning methods for image guided radiation therapy (IGRT) may be very sensitive to differing 
number of density values used for modeling of bones, segmentation accuracy of bones and geometric accuracy 
of the chosen methods in general. Thus, the published results may not be generalizable to methods that use auto-
mated delineation of bones. Feasibility of such pseudo-CT method should be verified independently by realistic 
use of the images where a human observer registers the DRR images to kV-radiographs.
This study compares MRCAT and CT based DRRs in IGRT for positioning of patients for determining the 
treatment isocenter locations for daily treatments. The quantitative assessment of suitability of an MRCAT DRR 
for this purpose is done by simulating the standard clinical workflow of registering DRRs and planar radiographs 
manually. Planar radiographs (kV-images) taken before the treatment are registered with the MRCAT images 
and the registration results are compared with those obtained by using the CT-based DRRs. To authors knowl-
edge, a thorough method comparison study has not been conducted to assess the sources of difference between 
CT and pseudo-CT based DRR patient positioning. For the first time, we analyze the impact to both systematic 
and random errors. Based on the impact to the required clinical target volume (CTV) margin, we derive an 
acceptance criterion for the use of pseudo-CT based DRRs.
Methods
Study design and image acquisition
The study cohort consists of 20 prostate cancer patients treated with external beam radiotherapy in the Docrates 
Cancer Center, Helsinki Finland. Patients were treated according to Docrates’ clinical protocol for prostate cancer 
patients that is based on pelvic CT simulation and additional MR images that are registered with the planning 
CT for target and OAR contouring. In this study, secondary MR image set was taken that allowed retrospective 
comparison between CT and MR-based DRRs. Thus, the treatment of the patients was not affected due to the 
study. The study protocol was approved by the Helsinki University Hospital Coordinating Ethics Committee.
Planning CT images were acquired using Siemens Sensation Open scanner with minimum of 40 cm FH 
coverage, 2 mm slices, 1 mm  ×  1 mm in-plane resolution, 120 kV tube voltage, mA modulation (Quality ref. 
mAs (CareDose) 190 mAs) and B31s reconstruction kernel. MR Images were acquired using Ingenia 1.5 T 
(n  =  8) or 3.0 T (n  =  12) scanners (software version 5.1.7 (n  =  11), 5.2 (2 cases) or 5.3 (n  =  7)) (Philips Medi-
cal Systems, B.V., Best, Netherlands). For all patients an axial 3D mDIXON sequence (T1-weighted, resolution 
1.04  ×  1.04  ×  2.50 mm3) covering full body contour in axial plane was taken and used for automatic generation 
of the MRCAT image. The scan protocol for MRCAT was fixed and specified by the manufacturer (Köhler et al 
2015). Full details of the sequence parameters are given in appendix B (stacks.iop.org/PMB/63/055009/mme-
dia). MR imaging time was below 200 s for all patients. Patients were immobilized similarly during the CT and 
MR simulation imaging. In the MR scan, patients were in supine position on a flat table and the anterior MR-coil 
was placed above the imaging volume using a coil holder provided by the manufacturer.
The kV positioning images were taken with an OBI system (On-Board Imager, Varian Medical Systems, Palo 
Alto, USA) integrated to a linear accelerator. Two orthogonal projections (AP or PA and LR or RL) were obtained 
for all patients (pixel-size: 0388  ×  0388 mm2, FOV: 30  ×  40 cm2).
MRCAT pseudo-CT generation
For pseudo-CT images, a commercially available MRCAT product, integrated with MR scanner software, was 
used to generate the images. In the MRCAT generating algorithm, CT-like density maps are generated fully 
automatically from an mDIXON image (Köhler et al 2015).
Bone structures in MRCAT are automatically segmented inside the body using the multiple contrasts pro-
vided by the mDIXON scan. Both the bone and outline segmentation employ a model-based segmentation 
approach trained on patient and volunteer mDIXON image datasets. The model contains information of average 
bone shape and how the shape varies in the training population. The model is adapted to an actual patient image 
using features (such as gray value edges) found within the image, while at the same time, a constraint for the 
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shape of the segmented structure prevents the segmentation from being attracted to a wrong position (Ecabert 
et al 2008).
Voxels inside the bone segmentation are assumed to contain either compact or spongy bone. An intensity 
threshold is used; lower intensities are considered to consist of compact bone, while voxels with higher intensity 
are assumed to contain spongy bone. The choice of the threshold value has been selected so that average bone 
density match with CT on population level.
Treatment planning
RT plans were created based on the simulation CTs according to the Docrates Cancer Center clinical practice. To 
study the DRRs generated from MRCAT, the structure sets and plans were copied from the original CT to rigidly 
registered MRCAT image and, thus, the isocenter position was the same, (within accuracy of the registration) in 
both plans. Pinnacle (Philips Healthcare, version 9.10) treatment planning system (TPS) was used for generating 
the DRRs (see figure 1 for an example of CT and MRCAT DRRs used in the study).
Evaluation
Five observers (4 radiographers and one physicist) registered the CT- and MRCAT-based DRRs to daily 
localization radiographs (kV-setup images). Registration was fully manual as is the most common clinical 
workflow at the site. Each image pair was evaluated three times by the same observer to obtain repeated 
measurements enabling the assessment of measurement quality in terms of inter- and intra-observer variability. 
In total, 300 (5 observers, 20 patients, 3 repetition) registration were performed per method.
Dedicated software was used for manual registration that was implemented using a commercial software 
package (MATLAB® 8.4.0.150421 (R2014b), The MathWorks Inc., Natick, MA, 2014). The registration tool 
recorded the couch shifts for the longitudinal (SI), lateral (LR) and vertical (AP) directions based on the regis-
tration of the images by an expert observer. The images were shown to the observers in a random order without 
revealing whether the DRR originated from an MRCAT or a CT image. The registration software is available as 
precompiled Matlab program as supplementary data and the source code to academic users upon email request 
from the authors.
To obtain a reference for the manual registrations, a registration between CT and MRCAT must be defined. 
Therefore, the mDIXON source scan was rigidly registered to the planning CT image and this transformation 
is then used as the MRCAT to CT reference registration. The registration shall eliminate minor orientation and 
translational difference between scans. See figure 2 for an illustration of the registrations that were performed 
and evaluated in this study.
Bland Altman plots
Bland Altman plots for repeated measurements were used for visual assessment of method differences. Limits 
of agreement (LoA) were adjusted for repeated measurements as suggested by Bland and Altman (Bland and 
Altman 1999). Measurements from multiple observers were not separated in the calculation of LoAs.
Figure 1. Example of CT (left column) and MRCAT DRR for anterior-posterior (bottom row) and left-right projections calculated 
in Pinnacle 9.10 TPS. HU density table is modified to filter out soft tissue contribution.
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Linear mixed effects model (LME)
The following mixed-effects model was used for evaluation of systematic difference and comparison of accuracy 
and reliability of the two methods:
yijk = µ+ ai + abij + εijk
 • i ∈ {1, 2, . . . , 20} is the patient index
 • j ∈ {1, 2, . . . , 5} is the observer index
 • k ∈ {1, 2, . . . , 3} is the kth measurement made by an observer on a certain patient
 • yijk  is the observed couch shift for patient i, observer j and measurement k
 • µ is the fixed effect population mean for the required couch-shifts
 • ai ∼ N(0,σa) is a patient level random effect that denotes the true deviation from µ for the ith patient
 • abij ∼ N(0,σab) is a random effect describing the bias of the jth reader when measuring the couch-shift for 
the ith patient. σab is the inter-observer repeatability, attributed to the standard deviation of the bias terms 
amongst all observers
 • εijk ∼ N(0,σε) is a random error made by the readers when making their kth measurement of the couch-
shift for the ith patient. Intra-observer repeatability is identified as the standard deviation parameter σε.
Stan statistical computing language with R implementation was used to fit the LME model to the measured 
data and to estimate the parameters of interest (Carpenter et al 2017). Full details of the statistical methods used 
in this manuscript together with R and RStan source code are given in the appendix. Similar LME model has been 
used for an IGRT method comparison study by Roy et al (2015).
Assessment of impact to total geometric deviation
Geometric accuracy of image guidance in RT directly affects required treatment margins and outcomes. 
Depending on whether a source of error is introduced in the planning phase or randomly during each fraction, 
the contribution to total uncertainty is either systematic or random (Van Herk 2004). Similarly, introduction 
of MRCAT reference image in RT can introduce both systematic and random error compared to CT-based 
workflow (see table 1). Systematic and random errors were analysed separately since their contribution to total 
uncertainty is different (Van Herk 2004).
To assess the differences in the systematic and random uncertainties between the two methods, the following 
derived metrics were used:
Figure 2. Illustration of registrations used in the study: MRCAT MR-source mDIXON images were rigidly registered to the 
simulation CT using bones making the reference registration (R1) for the comparison of manual 2D registrations between MRCAT 
DRRs (R3) and CT DRRs (R2) to the kV radiographs.
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∆sys = |∆µ|+ σ∆a
∆σrand =
√
σ2ab.MRCAT + σ
2
ε.MRCAT −
√
σ2ab.CT + σ
2
ε.CT,
where ∆sys is a random variable describing the systematic uncertainty and difference in registrations. It 
consists of the difference in population mean ∆µ and standard deviation of difference in patient registrations, 
∆ai = aCTi − aMRi , denoted as σ∆a. Furthermore, ∆σrand  is a random variable describing the difference in 
random registration error between the two methods consisting of both inter- and intra-observer variability.
To assess that a MR-only solution will improve the total geometric accuracy of RT workflow, the increase in 
registration uncertainty must be weighed against the reduction of the registration uncertainty present in a dual 
modality workflow. In RT, uncertainties can be linked directly to the required PTV margins and assessment of 
method agreement should reflect the impact to total uncertainty of compared workflows.
As proposed by Van Herk (2004) and Roy et al (2015), the sufficient CTV to planning target volume (PTV) 
margin can be expressed as:
mPTV = 2.5Σ+ 0.7σ
where Σ (here ∆sys) is the systematic and σ (∆σrand  in this study) is the random spatial uncertainty. We use 
this weighting of the two error components in the assessment of significance of the difference between CT and 
MRCAT registrations. Consequently, for MRCAT based workflow to be as good as or better than CT based 
workflow, the following condition must be met for all three directions:
Pr
(
mMRCATPTV −mCTPTV < 0
)
 0.95.
That is, the probability that the required PTV margin in MR-only workflow is smaller than in the dual modality 
workflow is larger than 95%.
An estimate for registration error of 2 mm from literature was used is our assessment (Roberson et al 2005). 
In addition, we calculate an estimate of registration error for which there is 95% probability that required margin 
in MR-only workflow is smaller.
Results
Bland Altman plots
The mean difference between the methods [±95% LoA] were  −0.5 [−3.2 to  +2.3] mm, +0.1 [−2.4 to  +2.6] 
mm and  +0.1 [−1.6 to  +1.7] for vertical, longitudinal and lateral directions, respectively (see figure 3). The 
repeatability coefficients were (CT versus MRCAT) 2.1 mm versus 2.6 mm, 1.4 mm versus 2.1 mm and 1.2 mm 
versus 1.4 mm for vertical, longitudinal and lateral directions.
Systematic differences
No difference in population mean ∆µ between CT and MRCAT based positioning were observed in lateral 
or longitudinal directions (see figure 4, P (∆µ < 0)  =  0.34). However, for vertical direction a statistically 
Table 1. Grouping the method comparison disagreement to systematic and random components.
Difference 
component Explanation Origin of difference Contribution to MRCAT registration error
∆µ Systematic difference in 
the population mean over 
all registrations of the two 
methods
Systematic difference between MR-
CAT and CT bone structures for the 
cohort of patients or systematic error 
in MR-to-CT reference registration
Systematic difference between MRCAT and 
CT bone structures results into systematic 
geometric deviation for the whole  
population in RT workflow
∆a (σ∆a) Difference in patient mean 
between CT and MRCAT 
based registration. SD of ∆a 
is denoted as σ∆a
Difference between MRCAT and CT 
bone structures varying from patient 
to patient or random error in  
MR-to-CT reference registration
Random difference between MRCAT and 
CT bone structures results to systematic 
geometric error in RT workflow for a  
patient and random error for a population
σ2ab. CT and 
σ2ab. MRCAT
The inter-observer repeat-
ability (variability) for CT 
and MRCAT DRR registra-
tions
Difference in the bone representation of 
CT and MRCAT might cause changes 
to inter-observer variability reflected 
by σab
Increased inter-observer variability would 
cause an increase of random error in RT 
workflow
σ2ε. CT  and 
σ2ε. MRCAT
The repeatability (intra-
observer variability) of 
registration in each method
Difference in the bone representation of 
CT and MRCAT might cause changes 
to inter-observer variability reflected 
by σε
Increased intra-observer variability would 
cause an increase of random error in RT 
workflow
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significant offset of (mean [95% CI])  −0.49 [−0.85 to  −0.13] mm was detected (P (∆µ < 0)  >  0.99). The 
standard deviation of patient offsets σ∆a was 0.29 [0.21–0.36] mm, 0.50 [0.40–0.63] mm and 0.63 [0.48–0.76] 
mm lateral, longitudinal and vertical directions.
Random setup errors
Inter-observer variation was not significantly different between CT and MRCAT based DRR to kV-image 
registrations in longitudinal (P (σab,MRCAT > σab,CT) = 0.58) or lateral (P (σab,MRCAT > σab,CT) = 0.52) 
directions. However, the largest difference was observed in vertical direction being statistically significant 
(P (σab,MRCAT > σab,CT) > 0.99) whereas smaller deviation was measured in longitudinal direction (see figure 5). 
In lateral direction, inter-observer variability was smallest and almost identical between the two methods.
A statistically significant difference was observed in intra-observer variability between CT and 
MRCAT based DRR to kV-image registrations in vertical, longitudinal and lateral directions (see figure 5, 
P (σε,MRCAT > σε,CT) > 0.99). The largest difference between methods was observed in longitudinal direction 
and smallest in lateral direction.
Effect on total uncertainty and on required PTV margin
The estimate of the parameter describing the systematic difference between MRCAT and CT based DRR-to-kV 
registrations, ∆sys, was (Maximum a posteriori, MAP [95% CI]) 1.04 [0.65–1.50] mm, 0.93 [0.65–1.44] mm, and 
0.58 [0.44–0.91] mm in vertical, longitudinal and lateral directions (see figure 6). The increases in total random 
uncertainty were estimated to be below 0.5 mm for all directions being (MAP [95% CI]) 0.31 [0.15–0.48] mm, 
0.24 [0.12–0.40] mm and 0.06 [−0.00–0.15] mm for vertical, longitudinal and lateral directions.
When registration errors were larger than 1.7 mm, 1.5 mm, and 1.1 mm in vertical, longitudinal and lateral 
directions, statistically significantly smaller CTV to PTV margin was needed in MR-only workflow.
Discussion
New pseudo-CT methods are increasingly introduced in the field (Edmund and Nyholm 2017). It is essential 
to note that assessment of the impact of using such methods to total geometric accuracy is as important as 
dosimetric accuracy. Currently, assessments of dosimetric accuracy outnumbers assessments of impact to other 
areas of uncertainty in RT. Thus, studies and methods assessing overall impact of pseudo-CTs beyond dose 
accuracy are needed.
In this study, we measured both accuracy and precision of MRCAT DRR to planar kV-image registration 
for IGRT of pelvic EBRT. According to the results, average positioning differences were  −0.5 mm, 0.1 mm 
and  −0.1 mm in vertical, longitudinal and lateral directions, respectively. These figures are similar to what has 
been reported for DRR to kV registrations for pseudo-CTs based on manually contoured bone segmentations 
in a similar measurement setup (Korhonen et al 2015). Namely, the authors reported average positioning differ-
ences (±SD) of  −0.3  ±  1.0 mm, 0.2  ±  0.9 mm and 0.1  ±  0.5 mm for vertical, longitudinal, and lateral, direc-
tions. Prior MRCAT DRR evaluation by Tyagi studied the quality of DRRs using a non-clinical workflow of 
automatically registering CT and MRCAT DRRs with an algorithm. The average match for all the patients was 
0.3  ±  0.4 mm, 0.03  ±  0.6 and 0.5  ±  0.8 mm in lateral, vertical and longitudinal direction respectively. Unfortu-
nately, their results cannot be compared to our manual DRR to kV-image registration study since the figures by 
Tyagi et al do not contain the uncertainty resulting from DRR to kV-image registration nor observer variation 
and, consequently, is not estimate of clinical performance of the method.
Figure 3. Bland Altman plot for vertical, longitudinal and lateral direction with LoA and mean difference. Obs1-5 show the 
registration differences between methods per observer.
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Alternative methods for assessment of DRR feasibility have also been reported. Unlike in our study, Kim et al 
(2015) used a bounding box width difference for assessment of geometric accuracy of their pseudo-CT method 
giving 0.4  ±  1.7 mm and  −0.6  ±  1.0 mm AP and RL DRRs, respectively. Furthermore, Chen et al used a set of 
eight measurement points defined in both CT and manually segmented pseudo-CT to assess the feasibility of cal-
culated DRRs for IMRT treatment of prostate carcinoma. The maximum difference for a point location between 
pseudo-CT and CT was 1.3  ±  1.6 mm when averaged over the study population. However, either Kim or Chen 
Figure 4. Systematic difference between CT and MRCAT-based DRR registrations to kV-images for VRT (dash-dotted), LAT (solid) 
and LNG (dashed) directions with mean (vertical bar) and 95% credible interval (horizontal bar). Left: difference of population 
means ∆µ. Right: standard deviation of patient offset σ∆a.
Figure 5. Posterior distribution of intra- (to row) and inter-observer (bottom row) variability in vertical (left), longitudinal 
(middle) and lateral (right) directions for CT (solid) and MRCAT (dashed) DRR to kV-radiograph registrations. Horizontal bars 
indicate 95% credible intervals [95% CI] and vertical bars show the maximum a posteriori (MAP) point of the distribution.
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et al do not report performance metrics measured based on image registrations. In addition, several authors 
(Kim et al 2015, Korhonen et al 2015) have reported image similarity scores between pseudo-CT and planning 
CT DRR. Unfortunately, the similarity metrics have a disadvantage of not measuring positioning accuracy or 
precision achievable with the investigated method. Furthermore, when using similarity scores, it’s difficult to 
assess the impact to total geometric accuracy and acceptance criteria may not be defined.
Measured difference between registrations in CT and MRCAT based workflow include both true difference 
and measurement noise. The measurement noise stems mainly from two sources. First, registrations between 
CT and kV-radiographs are affected by uncertainties stemming from the ~1 mm-pixel sizes and the ~2 mm-slice 
thickness in the reference images contributing to errors in calculated DRRs (Hurkmans et al 2001). Second, the 
residual errors from planning CT to mDixon source image registrations are contributing to the systematic offsets 
for each patient. In this study patient positioning uncertainties with MRI-based reference images were analyzed 
by assuming that the registrations between MRCAT and CT can be regarded as an error free reference for correct 
patient position. Since such baseline assignment is not truly error free and CT based registration is affected by 
uncertainties, it is likely that the actual registration uncertainty with MRI- based DRR is smaller than reported in 
this study. Particularly, when considering the significance of the observed small systematic differences one needs 
to acknowledge that due to chosen study design these differences can result from MRCAT properties or from 
the registration uncertainties in the MR to CT reference registration (R1). To our knowledge, there is no simple 
direct method to measure the performance of MRCAT DRRs for patient position verification purposes using 
human observers. Thus, our method was to compare to the ‘gold standard’ CT-based workflow.
Unlike the systematic differences, inter- and intra-observer variability are not affected by the uncertainties 
of the reference registration. Thus, they can be used for measuring the random positioning error independently 
for both MRCAT and CT-based DRRs. More importantly, in any method comparison study, simultaneous esti-
mation of repeatability, through repeated measurements of identical conditions, and agreement are necessary 
in order to analyze the origin of discrepancies between methods (Myles and Cui 2007). No prior studies assess 
intra-observer variation in image guided patient positioning workflow for prostate cancer patients.
Based on obtained registrations, the inter-observer variability was not significantly different in longitudinal 
or lateral directions but was slightly increased compared to CT in vertical direction. The increase might be due to 
degraded visibility of the anterior outline of the pubic bone in the MRCAT DRRs. Intra-observer variability was 
significantly larger for MRCAT DRRs than CT DRRs in vertical and longitudinal directions. However, the total 
increase in random registration error was below 0.5 mm for all directions and can be considered insignificant in 
the context of total geometric uncertainties for pelvic RT.
Based on the results, given that there is an uncertainty associated with CT-to-MR registration larger than 
1.7 mm, 1.5 mm, and 1.1 mm in vertical, longitudinal and lateral direction, it’s likely that use of MR-only has 
a positive effect to the total geometric accuracy. In the literature uncertainties of 2 mm have been reported for 
Figure 6. Effect on total systematic (left) and random (middle) geometric uncertainty and probability of reduced required CTV to 
PTV margin for MRCAT compared to CT workflow (right) for VRT (dash-dotted), LAT (solid) and LNG (dashed) directions with 
MAP (vertical bar) with 95% credible interval (horizontal bar). On the right, above points where probability is larger than 95%, 
required margin for MRCAT is statistically significantly lower. Circular marks indicate the points where probability was evaluated.
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prostate RT (Roberson et al 2005). Thus, we conclude that in terms of total geometric accuracy benefits of using 
MRCAT likely outweigh the small increase in MRCAT DRR-based positioning uncertainty. However, as registra-
tion errors were not quantitated in this cohort of patients, further research is needed to confirm our findings.
An important patient positioning workflow for EBRT of prostate cancer is based on implantable fiducials 
(Parker and Damyanovich 2003). The workflow is also feasible with MRCAT (Tyagi et al 2017) since most of the 
fiducials are accurately localized in MR images (Parker and Damyanovich 2003, Jonsson et al 2012, Kapanen et al 
2013) and their contours on DRR images can be used for target position verification and the clinical workflow is 
feasible (Kapanen et al 2013, Tyagi et al 2017). However, automatic and robust detection of fiducial markers from 
MR-images remains a challenge and is a subject of active research (Ghose et al 2016, Dinis Fernandes et al 2017, 
Gustafsson et al 2017, Maspero et al 2017).
The study population consisted of only prostate cancer patients. For other indications in the pelvis, including 
also female patients, we have demonstrated the feasibility of MRCAT generation, geometric accuracy and dose 
accuracy, in an earlier study (Kemppainen et al 2017). Thus, the results obtained in this study are considered 
applicable for pelvic anatomy in general. However, further studies are needed to verify the findings and assess 
robustness of MRCAT for female population.
Currently, contraindications for the use of MRCAT are metal in the imaging volume, such as a metal pros-
thesis in the hip region, bone anomalies or bone disease in the pelvic area and body diameter in the pelvic area 
exceeding 50 cm in AP direction. The risk of using contraindicated MRCAT images for RT is mitigated by imple-
menting a safety check in the MRCAT algorithm that prevents the reconstruction of the pseudo-CT in case 
of atypical bony anatomy or presence of hip implants, for example. Use of MRCAT DRRs for contraindicated 
patients is beyond the scope of this article and requires further studies.
Use of volumetric positioning image (kV CBCT) is becoming more common due to improved visualization 
of the daily variation in the anatomy (Moseley et al 2007). For prostate, MRCAT could be used also with CBCT-
based position verification utilizing implantable fiducial’s for registration to daily CBCT (Tyagi et al 2017). In 
general, however, soft-tissue based registration between daily CBCT and MRCAT for position verification needs 
to be investigated in subsequent studies since MRCAT, with only two soft-tissue density values, might not be 
robustly registered to a CBCT image.
This study advances research and supports future clinical implementation of MRI-only IGRT by presenting 
a Bayesian linear mixed effects model (LME) method comparison approach for assessing accuracy and precision 
of patient positioning. Our analysis method is available, uses widely used open source software and could be 
easily utilized for assessment of other anatomies or methods. Particularly, we used the LME to compare MRCAT 
pseudo-CT method to a CT-based workflow and demonstrated the feasibility of the method for kV planar imag-
ing IGRT for pelvic anatomy.
Conclusions
The MRCAT pseudo-CT method provides clinically acceptable accuracy and precision for patient positioning 
for pelvic RT based on planar DRR images. Use of MRCAT method is associated with a small increase in precision 
and small systematic difference compared to CT. However, when the slight increase in uncertainty is compared to 
the uncertainty in CT-to-MR registration in dual modality workflow, MRCAT can be considered more accurate 
in terms of total accuracy when registration errors are larger than 1.7 mm, 1.5 mm, and 1.1 mm in vertical, 
longitudinal and lateral directions.
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A B S T R A C T
Background and purpose: The clinical feasibility of synthetic computed tomography (sCT) images derived from
magnetic resonance imaging (MRI) images for external beam radiation therapy (EBRT) planning have been
studied and adopted into clinical use recently. This paper evaluates the dosimetric and positioning performance
of a sCT approach for different pelvic cancers.
Materials and methods: Seventy-ﬁve patients receiving EBRT at Turku University Hospital (Turku, Finland) were
enrolled in the study. The sCT images were generated as part of a clinical MRI-simulation procedure. Dose
calculation accuracy was assessed by comparing the sCT-based calculation with a CT-based calculation. In ad-
dition, we evaluated the patient position veriﬁcation accuracy for both digitally reconstructed radiograph (DRR)
and cone beam computed tomography (CBCT) -based image guidance using a subset of the cohort. Furthermore,
the relevance of using continuous Hounsﬁeld unit values was assessed.
Results: The mean (standard deviation) relative dose difference in the planning target volume mean dose
computed over various cancer groups was less than 0.2 (0.4)% between sCT and CT. Among all groups, the
average minimum gamma-index pass-rates were better than 95% with a 2%/2mm gamma-criteria. The differ-
ence between sCT- and CT-DRR-based patient positioning was less than 0.3 (1.4) mm in all directions. The
registrations of sCT to CBCT produced similar results as compared with CT to CBCT registrations.
Conclusions: The use of sCT for clinical EBRT dose calculation and patient positioning in the investigated types of
pelvic cancers was dosimetrically and geometrically accurate for clinical use.
1. Introduction
Computed tomography (CT) is currently the primary imaging
modality for providing anatomical and tissue density information in the
external beam radiation therapy (EBRT) planning of pelvic cancers.
Magnetic resonance imaging (MRI) is widely used as a supplement to
the CT imaging [1–3] . The most signiﬁcant advantage of MRI over CT is
its better soft-tissue contrast, which results in a more accurate gross
tumor volume and organ at risk (OAR) delineation [4–7] . Additional
beneﬁts include the usage of non-ionizing radiation and the versatility
of acquisition sequences allowing the cancer- or organ-speciﬁc imaging
methods [5] .
A major drawback of multi-modality imaging in EBRT is the residual
registration error remaining when the images from two or more
modalities are registered with each other [8] . Recent advances in the
use of MRI promise to eliminate the registration error by using only the
MR images for planning and dose calculation in the EBRT of prostate
and brain cancer (see the recent reviews [9–11] ). In an MRI-only
workﬂow, so-called synthetic CT (sCT) images are generated from the
magnetic resonance (MR) images, providing the tissue density in-
formation for dose calculation and reference images for patient position
veriﬁcation. Over recent years, commercial solutions for obtaining the
sCT for prostate cancer patients have been introduced [12,13] .
A commercially available solution for the sCT generation was used
in this work. It has been shown that the solution can be used for an
accurate dose calculation and patient positioning for prostate cancer
patients [13,14] . In addition, its feasibility for other indications in the
pelvic anatomy was demonstrated in our earlier study [15] . However,
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the bulk assignment of Hounsﬁeld unit (HU) values limits the soft-tissue
characterization, and consequently affects the ability to verify treat-
ment position based on a tissue contrast. In addition, the sCT methods
suitable for prostate EBRT may not be directly applicable to other pelvic
targets due to larger treatment volumes and higher patient demo-
graphic variability, both characteristic for the non-prostate pelvic
cancer. Thus, additional validation of a sCT solution for general pelvic
imaging is required.
The feasibility of sCT methods for general pelvic anatomy including
the assessment of both dosimetric and positioning accuracy have not
been studied within a single study. Several groups have assessed the
dosimetric and positioning for prostate cancer with comparison of
continuous HU and bulk HU assignment (see e.g. [16–19] ). Two recent
studies have evaluated the feasibility of MRI-only workﬂow for rectal
cancers [20,21] . However, to the best of our knowledge, only the do-
simetric accuracy has been evaluated for gynecological cancers
[22–24] .
The aim of this study was to evaluate the feasibility of an MRI-only
method in terms of dose calculation, position veriﬁcation and geometric
accuracy in EBRT for the pelvic anatomy in general. In addition, we
have evaluated the necessity of continuous HU values in sCT images for
dosimetric and positioning accuracy for prostate cancer patients. This
research addressed the use of sCT in pelvis which included the cone
beam computed tomography (CBCT)- and digitally reconstructed
radiograph (DRR)-based position veriﬁcation workﬂows. Furthermore,
both bone- and soft-tissue-based registration workﬂows for CBCT were
evaluated.
2. Materials and methods
2.1. Patient cohort and image acquisition
The study cohort consisted of 75 consecutive patients referred to
EBRT of pelvic cancers at the Department of Oncology and
Radiotherapy of Turku University Hospital in Turku, Finland. The pa-
tients were enrolled in between October 2017 and August 2018. The
Ethical Committee of the Hospital District of Southwest Finland ap-
proved the study, and an informed consent was obtained (reference
code: Dnro 116/1801/2017).
There were 20 (27%) female and 55 (73%) male patients divided
into ﬁve groups each consisting of 15 patients. A total of 45 (60%)
patients had a prostate cancer of whom 15 underwent deﬁnitive, 15
postoperative, and 15 regional pelvic lymph node EBRT. The remaining
two groups consisted of 15 patients with rectal and 15 patients with
gynecological cancer, respectively (see the Table 1 for further details).
The CT simulation images were acquired using the Aquilion LB
(Toshiba Corp., Tokyo, Japan) scanner with 2-mm-thick slices,
1 × 1 mm 2 in-plane resolution, 120 kV tube voltage, and tube current
modulation in cranio-caudal (CC) direction (Toshiba Sure-Exposure 3D
SD 12.50). The MR images were recorded with the Ingenia 1.5T HP (sw.
version 5.3.1, Philips MR Medical Systems International B.V., Best,
Eindhoven, The Netherlands) scanner. For all patients, an axial T1-
weighted three-dimensional (3D) mDIXON sequence [13] was acquired
covering the full body contour (see the Supplementary Table 1 for MRI
parameters). The MR images were used as a source for the sCT gen-
eration. Patients were positioned similarly during the imaging for CT
and MRI simulation using the same patient positioning devices (in-
cluding knee support) as during treatment. During the MRI scan, pa-
tients were placed in a supine position on a ﬂat EBRT couch top and an
anterior MRI-coil was placed above the imaging volume using a coil
holder to prevent body outline deformation.
The planar radiograph and CBCT positioning images were acquired
with the on-board imager system integrated to a linear accelerator
(Varian Medical Systems Inc., Palo Alto, CA, USA). In the DRR study,
two orthogonal projections (anterior-posterior (AP) or posterior-ante-
rior (PA); and left–right (LR) or right-left (RL)) were obtained for all
patients with a pixel size of 0.388 × 0.388 mm 2; a ﬁeld-of-view (FOV)
of 30 × 40 cm 2. For volumetric imaging, the CBCT images were ac-
quired using 125 kV and 80 mAs with a 1 × 1 mm 2 in-plane resolution,
2-mm-thick slices and 160 mm coverage.
2.2. Synthetic CT generation
Two different versions of the sCT generation method (Magnetic
Resonance for Calculating Attenuation, MRCAT, Philips Oy, Vantaa,
Finland) were used in this study. The ﬁrst version used a bulk assign-
ment of HU values, which is referred to as sCTb in this study. The
second version was an improved version of the MRCAT providing
continuous HU values called sCTc hereafter. In the subgroup of patients
receiving the radical treatment for prostate cancer (N = 15), both
versions were generated for comparison of the methods. For other four
cancer groups, only the sCTc was generated to evaluate the new
method.
In the sCTb generating algorithm, the CT-like density maps were
computed from the mDIXON MR images in a two-step approach
[13,25,26] . In the ﬁrst step, the content of the MR image was cate-
gorized into ﬁve classes. In the second step, each voxel was assigned the
following HU: spongy bone (198 HU), compact bone (949 HU), fat (-86
HU), and water-rich tissue (42 HU).
The sCTc and sCTb used the segmentation of bones and soft-tissue
based on mDIXON MR images. However, instead of the bulk assign-
ment, the continuous HU values were used based on fat/water fraction
within the voxels. In addition, the voxels on the body outline could
partially contain air for modeling the partial volume effect. The sCTc
images were obtained from the manufacturer while the sCTb images
were generated at the scanner console. See the electronic supplemen-
tary material for details of the sCT generation.
2.3. Image processing
The CT images were rigidly registered to the sCTc and resampled to
the same pixel grid using B-spline interpolation with the Elastix 4.9.0
[27] program. The registration parameters were the same used by
Maspero et al. [28] for the registration between CT and sCT images. In
CT images, the air cavities in the bowel and rectum were ﬁlled for all
patients with 0 HU using the Matlab scripts (MATLAB ® 8.4.0.150421
(R2014b), The MathWorks Inc., Natick, MA, USA). The ﬁlling was
equivalent to density override by water in the treatment planning
Table 1
Patient demographics and structure details within ﬁve different cancer groups (mean (standard deviation)) (PTV: planning target volume).
Pelvic lymph node Rectal cancer Gynecological cancer Prostate post-operative Prostate deﬁnitive
Patient demographics
Average age (years) 65.7 (6.2) 68.2 (10.6) 67.3 (14.0) 68.7 (6.8) 70.3 (8.0)
Sex (males/females) 15/0 10/5 0/15 15/0 15/0
Structure details
PTV volume (cm 3) 1233 (4 4 3) 1621 (6 1 1) 1340 (7 1 6) 376 (1 0 2) 130 (43)
Bladder volume (cm 3) 231 (1 3 9) 287 (1 8 9) 225 (1 1 8) 239 (1 2 4) 281 (2 2 9)
Rectum volume (cm 3) 92 (41) 155 (34) 86 (43) 78.84 (37) 91 (43)
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system (TPS) corresponding to a clinical practice used with patients
encompassing large air volumes at our institution. The same approach
was used [20] or suggested to be used [29] in the dosimetric evalua-
tions of MRI-only methods in order to avoid confounding dosimetric
differences not related to the sCT methods.
2.4. Dose calculation accuracy
The dosimetric agreement between planning CT and sCT was eval-
uated by recalculating the clinical plans in the Eclipse 13.6 (Varian
Medical Systems Finland Oy, Helsinki, Finland) TPS using the sCT for
inhomogeneity correction, an anisotropic analytical algorithm (AAA)
for dose computation and a volumetric modulated arc (VMAT) delivery
technique. The voxel grid size for optimization and dose calculation
was set to 2.0 × 2.0 × 2.0 mm 3. The dosimetric agreement between CT
and sCT was evaluated per cancer group for all patients. The evaluation
metrics included dose-volume histogram (DVH) comparison for the PTV
and OARs, 3D gamma analysis and dose comparison statistics.
The DVH evaluation was based on the structures that were copied
from the planning CT to sCT based on rigid registration. Minimum,
median and maximum (D 2%, D 50% , D 98% ) dose points were evaluated
for the PTVs while volumes of V 95% and V 70% were assessed for the
OARs. The results were computed as a relative difference with respect
to prescribed dose ( )D pCT D CTD( ) ( )presc . for dose points or structure volume
( )V pCT V CTV( ) ( )struct . for volume points.
The 3D gamma analysis was performed using the Plastimatch 1.7.3
(http://plastimatch.org/index.html ) open source software for image
registration. Various gamma-index pass-rate criteria and dose cut-off
values were evaluated using a global gamma-index relative to the
maximum dose. The maximum value of gamma-index to compute was
set to the default value of two.
2.5. Image similarity and body outline distortion
The differences between CT and sCT images were evaluated by
computing a mean absolute error (MAE) and a mean error (ME) be-
tween the HU values within the intersection of the body contours of the
two images. In addition, to assess the body outline correctness in sCT,
the difference between CT and sCT body outline was computed for
different CC positions at the distances from −150 to 150 mm from the
MRI scanner isocentre. Furthermore, the computed body outline dif-
ferences were compared with the measured geometric distortion to
assess the origin of the differences in body outline.
The assessment ofimage similarity and body outline was performed
using a Matlab program. First, the program evaluated the body outline
difference at each CC-position for all patients as function of angle. Then
the information at each CC-location was condensed by computing the
mean absolute difference and standard deviation of the mean absolute
difference over all angles and patients.
The MRI-system induced geometric distortions were evaluated by
imaging a large 3D phantom containing a regular grid of MRI-positive
markers. The parameters of the imaging sequence affecting geometric
accuracy (sequence type and receiver bandwidth) were matched with
the sCT source image. First, the markers were located, and their posi-
tions were compared with the phantom structure in order to compute
the geometric distortion at the marker locations. Then, for each in-
cluded patient, the obtained distortion map was interpolated to the
positions deﬁning the body outline structure. Finally, the geometric
distortion was evaluated over a study cohort (see a detailed description
in [15] ).
2.6. Positioning accuracy and precision
A subset of the cohort was selected for the assessment of both the
DRR- and CBCT-based position veriﬁcation before each treatment
fraction.
2.6.1. DRR
In the DRR study, 20 consecutive patients were selected consisting
of nine females with three rectum and six gynecological cancer patients
and eleven males with seven prostate and four rectum cancer patients.
The manual registrations between CT-DRR and planar radiograph were
compared with the manual registrations between sCT-DRR to planar
radiograph (see the Fig. 1 for visualization of DRRs and Supplementary
Fig. 1 for visualization of performed registrations). The manual
Fig. 1. Example DRR images from Eclipse treatment planning system using bone rendering (HU values less than 100 and above 1000 omitted). CT (left), sCTc with
continuous HU values (middle), and sCTb with discrete HU values, (right) (DRR: digitally reconstructed radiograph, HU: Hounsﬁeld unit, CT: computed tomography,
sCT: synthetic computed tomography, R: right, A: anterior).
R. Kemppainen, et al. Physics and Imaging in Radiation Oncology 11 (2019) 1–8
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registrations were performed using a Matlab-based tool simulating the
paired registration of planar kV and DRR images. The observers were
asked to perform manual registrations of the paired projections shown
to them in random order. The clinical set-up correction protocols per
cancer type were not used but all of the cases were registered using the
same procedure.
In total, ﬁve observers (two medical physicists and three radio-
graphers) performed registrations with three replications of each re-
gistration (20 cases × 2 methods × 3 repetitions = 120 number of re-
gistrations per observer). In addition, for seven prostate cancer patients
both sCTc and sCTb were evaluated to compare the relevance of con-
tinuous HU versus bulk HU assignment in the sCT generation (adding 7
cases × 1 method × 3 repetitions = 21 registrations per observer). The
fraction used was randomly chosen.
The assessment of positioning accuracy was performed by com-
puting the mean and standard deviation (SD) of the difference of re-
gistrations obtained by CT-DRR and sCT-DRR.
2.6.2. CBCT
The CBCT-based veriﬁcation of patient position was studied by
comparing the registrations between CT to CBCT and sCT to CBCT re-
lying on either bony structures or soft-tissue contrast for a subset of ten
patients. In each registration methods, ten consecutive patients with a
randomly chosen fraction were selected and the registration between
the images were performed in the Offline Review module of Eclipse
TPS. The registration was restricted to translations corresponding to the
treatment couch movements available in the linac.
The performance of the bone-based registration was assessed as a
difference between CT and sCT positioning. The observer was in-
structed to position the patient using automatic registration tools like
prior to the treatment. Both PTV and OAR structures were visible
during the registration. The bone registration study cohort consisted of
four women with gynecological cancer and six men receiving treatment
for post-operative prostate cancer.
In the evaluation of soft-tissue-based position veriﬁcation, two da-
tasets were prepared using the data from the radical prostate cancer
group. The ﬁrst set contained original CT, sCT and CBCT images, where
the ﬁducial markers were visible in the images directly or as contours.
In the second set, the markers were removed from CT, sCT and CBCT
images using the Photoshop 6 (Adobe Inc., City of San José, CA, USA)
image processing tool. First, the DICOM (digital imaging and commu-
nications in medicine) images were imported as 16-bit images enabling
preservation of the data using the functionality integrated to the
Photoshop. Then, the seeds were manually removed using the patch
and healing brush tools. After removal, the images were stored as 16-bit
TIFF (tagged image ﬁle format) images and again as DICOM images
using Matlab. Finally, the images were imported back to the TPS for
registration. Three evaluators performed registrations for both image
sets (see the Supplementary Fig. 2 ) and the difference between marker-
based and soft-tissue-based registration was used as a goodness metric
of registration for both modalities independently.
2.7. Statistical analysis
Statistical analysis was conducted using Minitab (version 17,
Minitab Inc., State College, PA, USA) numerical analysis software. The
data between sCTc and sCTc were tested whether the means of the two
dependent groups differ using the two-sample t-test.
3. Results
3.1. Dose difference
The mean (SD) dose differences of the PTV mean dose computed
over cancer groups, each with 15 patients, were less than 0.2 (0.4)%
between sCTc and CT. The mean dose differences for studied volumes
were less than −0.3 (0.6)% (see the Table 2 ) for OARs. Two outliers for
the rectum DVH comparison were identiﬁed in the gynecological cancer
group. Without including the two outliers, the difference for the rectum
V95% was −0.1 (0.8)% [−1.1–1.3] (for visualization of the outlier
DVHs see the electronic supplementary material ).
The mean gamma-index pass-rate evaluation was highest for the
prostate cancer patients and lowest for the gynecological and rectal
cancer patients. Among all groups, the average pass-rates within vo-
lumes of V 10% were higher than 95% with 2%/2mm gamma-criteria.
The lowest pass-rate was for the rectum cancer group being 96.2
(2.0)%. The mean relative dose differences were less than 0.3 (0.3)%
for all studied cancer groups and volumes ofinterest. The MAE was less
than 50 HU for all studied cancer groups (see the Table 2 ).
An example of gynecological cancer patient is illustrated in the
Supplementary Fig. 4 . More comprehensive set of results are presented
in the online supplementary material (see the Supplementary Table 2).
3.2. Bulk to continuous HU comparison
For prostate cancer patients, the mean (SD) dose difference, within a
volume receiving more than 10% of the prescribed dose, was −0.1
(0.2)% and −0.3 (0.2)% for sCTb and sCTc, respectively. Statistically
signiﬁcant differences were observed in the mean error (ME, p < 0.01)
of HU values, mean dose within V 10% (p < 0.01) and mean gamma-
index pass-rates with 2%/2mm gamma-criteria (p = 0.04) (see the
Supplementary Table 4).
3.3. Body outline and geometric analysis
The body outline differences and the MRI-system-induced geometric
distortion were the smallest close to the isocentre of MRI device.
Nearby the isocentre, the absolute difference of body outline between
CT and sCTc was 2 mm on average, but it increased farther away from
the isocentre and reached the average difference of 6 mm at 150 mm
(see the Fig. 2 ). The contribution of geometric distortion to the body
outline difference was less than 2 mm within the investigated volumes.
The systematic difference between CT and sCTc body outlines was
observed for various CC distances from the isocentre of MRI device (see
Fig. 2. Mean absolute body outline difference (solid blue line) and mean + 1SD
(dash-dotted line) between CT and sCT images. Mean body outline geometric
distortion (dashed red line), mean + 1SD (red dashed-dotted) and max distor-
tion (red dashed line) of the body outline due to geometric distortions of MR
images as a function of (cranio-caudal) distance from the isocentre of MRI
device (SD: standard deviation, CT: computed tomography, sCT: synthetic
computed tomography, MRI: magnetic resonance imaging). (For interpretation
of the references to colour in this ﬁgure legend, the reader is referred to the web
version of this article.)
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the Supplementary Fig. 3 ). The largest systematic differences were
present toward the cranial end of the studied FOV at angles corre-
sponding patient’s anterior direction (angle 0°). Towards the caudal
end, systematic differences were not found, but the random uncertainty
increased.
3.4. Positioning
3.4.1. DDR positioning
The mean (SD) difference between CT- and sCTc-based DRR posi-
tioning evaluated for 20 patients was −0.1 (1.4) mm, 0.3 (1.1) mm and
0.1 (0.8) mm, in AP, CC and LR direction, respectively (see Fig. 3 ).
The comparison of sCTb and sCTc was performed using subset of 7
patients. The mean (SD) difference between CT- and sCTc-based DRR
positioning was −0.2 (1.2) mm, 0.4 (1.3) mm and −0.1 (0.6) mm, in
AP, CC and LR direction, respectively. For sCTb, the difference was 0.2
(1.6) mm, 0.3 (1.2) mm and −0.1 (0.9) mm, respectively.
3.4.2. CBCT positioning
For the bone-based positioning studied with ten patients, the mean
(SD) observer differences were 0.1 (1.1) mm, 0.1 (0.6) mm and −0.0
(0.2) mm in AP, CC and LR directions, respectively (see the Fig. 4 ).
For the soft-tissue-based positioning in the AP direction, the mean
(SD) differences between ﬁducial markers- and soft-tissue-based regis-
trations were 0.5 (1.8) mm, 0.5 (1.8) mm and 1.1 (1.8) mm for CT, sCTc
and sCTb, respectively. In the CC direction, the mean (SD) differences
were −0.2 (1.1) mm, −0.6 (1.3) mm and −0.8 (2.3) mm, respectively.
Furthermore, the smallest registration differences were seen in the LR
direction, being 0.1 (0.7) mm, −0.4 (0.7) mm and −0.2 (0.6) mm for
CT, sCTc and sCTb, respectively.
4. Discussion
Pelvic cancer patients would beneﬁt from the use of sCT in terms of
decreased total uncertainties in EBRT [22–24] . This study aimed at
demonstrating dosimetric and positioning accuracy of using MRCAT
sCT with continuous HU values for the EBRT of pelvic cancers. This
study covered several possible positioning workﬂows that have not
been assessed previously. The results were relevant when aiming to
extend the use of sCT method to pelvic cancer patients.
The dosimetric accuracy was assessed by comparing sCT to CT-
based dose computation. The dosimetric differences between CT and
sCTc were found to be small among all cancer groups. Considering
mean (SD) gamma-index pass-rates of 98.0 (0.6)%, 96.2 (2.0)% and
Fig. 3. Left: Box-plot of differences between CT-DRR to planar kV-image and sCTc-DRR to planar kV-image registration for anterior-posterior (AP), cranio-caudal
(CC) and left–right (LR) directions evaluated using a group of 20 patients. Right: Box-plot of difference between CT-DRR to planar kV-image and sCT-DRR to planar
kV-image registration for AP, CC and LR directions evaluated for bulk HU (sCTb) and continuous HU (sCTc) sCT evaluated using a subset of seven patients. (CT:
computed tomography, DRR: digitally reconstructed radiograph, kV: kilovoltage, sCT: synthetic computed tomography, HU: Hounsﬁeld unit).
Fig. 4. Left: Box-plot of registration difference between CT-to-CBCT and sCTb-to-CBCT using bone-based registration in left–right (LR), anterior-posterior (AP) and
cranio-caudal (CC) direction. Right: Box-plot of registration differences between CT to CBCT and sCT to CBCT using soft-tissue contrast with respect to marker-based
registration in AP, CC and LR directions. (CT: computed tomography, CBCT: cone-beam computed tomography, sCT: synthetic computed tomography).
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96.5 (2.3)% using 2%/2mm gamma-criteria and mean (SD) dose dif-
ferences of −0.1 (0.2)%, 0.1 (0.3)% and −0.1 (0.3)% for the prostate
base, rectum and gynecological cancer patients, the dosimetric agree-
ment was found to meet the clinical acceptance criteria. Maspero et al.
[24] used a deep learning-based sCT approach and evaluated its ap-
plicability for pelvic cancer patients. They obtained pass-rates of 95.0
(2.3)%, 91.6 (3.3)% and 92.9 (3.7)% and mean dose difference of −0.1
(0.1), −0.2 (0.2) and −0.1 (0.3) for prostate, rectum and cervix cancer
patients using 2%/2mm gamma-criteria, respectively. Although re-
porting slightly lower agreement, their results were in line with this
study.
Wang et al. [21] obtained median gamma-index pass-rate of 99.9%
(99.4–100.0%) and medians of the dose difference averages were
0.21 Gy (0.2–0.3 Gy). In addition, Maspero et al. [20] evaluated the
feasibility of the same method used in this study (sCTb) for rectal
cancer patients obtaining the mean gamma-index pass-rate of 95.2
(4.0)% and mean dose deviation of −0.3 (0.2)% of prescription dose.
Liu et al. [22] evaluated the sCT method for gynecological cancer pa-
tients obtaining the PTV dose deviation of 0.2 (0.4) Gy for D 0.5cc and 0.3
(0.3) Gy for D 99% .
Liu et al. [22] and Maspero et al. [24] results showed that the do-
simetric agreement was decreased for rectum and gynecological cancer
patients in comparison to prostate cancer patients. According to the
body outline comparison between CT and sCT, the difference increases
farther away from the imaging isocentre along CC axis. However, this
was unlikely due to geometric distortion, which also increases with
growing distance from the isocentre, but rather due to differences be-
tween CT and MRI modalities. Thus, higher dosimetric disagreement for
patients with longer PTVs in CC direction might arise from these dif-
ferences. In addition to random daily variation in body outline due to
breathing and positioning, it has been suggested by Persson et al. that
systematic differences between body outlines on CT and MRI could be
attributable to longer scan time causing body relaxation [30] . Ad-
ditionally, according to these results the systematic difference in the
abdomen could be due to abilities of the two modalities to record the
breathing motion.
Interestingly, no major difference in dosimetric performance was
found between bulk HU and continuous HU sCT. This implies that al-
ready four tissue classes were adequate to capture the individual var-
iance in body composition and to produce clinically acceptable accu-
racy in the dose calculation for prostate cancer patients treated with
EBRT. Larger differences are typically reported between continuous HU
and bulk HU sCTs. Kim et al. [18] reported no signiﬁcant dosimetric
difference between continuous HU or bulk-HU sCTs but obtained higher
gamma-index passing-rate of 97.2% vs. 94.0% for continuous sCT
evaluated with 1%/1 mm gamma-criteria. Largent et al. [17] found that
the mean gamma-index pass-rate for continuous HU values (99.5%) was
signiﬁcantly higher than that of bulk density method (96.1%). Both Kim
et al. and Largent et al. used only two bulk densities: one for bone and
one for soft-tissue that could explain worse dosimetric agreement in
comparison to our results. In line with our earlier study, using the sCTb
[26] , the patient positioning accuracy was found to be at the clinically
acceptable level. However, when using continuous HU values for bone,
AP positioning precision was improved as compared with the bulk as-
signment of HU values (sCTb). This could be due to improved visuali-
zation of pubis in sCTc, as illustrated in Fig. 1 .
The mean difference between bone-based positioning between CT to
CBCT and sCT to CBCT was less than 0.2 mm in all directions. The result
was in agreement with earlier studies reporting sub-millimeter accuracy
for the bulk HU version of the used sCT method [13,20] . Here, for the
ﬁrst time the soft-tissue prostate positioning of a sCT method was
evaluated by comparing it to the ﬁducial marker-based reference. No
differences in the performance between CT and sCTc were observed.
However, for sCTb, the differences were slightly larger in the CC and AP
directions but not in LR direction. Thus, no major difference in posi-
tioning performance was found between the methods. In addition, the
use of smaller slice width for sCTc could also contribute to the observed
difference.
In the DRR and soft-tissue CBCT positioning studies, there were a
few outlier registrations as see in Figs. 3 and 4. For the DRR registra-
tions, the differences were greater that is expected for either CT or
MRCAT registrations alone as they were affected by the random error
related to DRR-to-kV registration uncertainty both for CT and MRCAT.
For soft-tissue-based registrations greater than 5 mm differences have
also been reported for 28% of the registrations when comparing to seed
based truth [31] . Thus, our results are in line with the reported values
in the literature. The large difference may result from the poor soft-
tissue visibility and artifacts in CBCT images.
Increasing the FOV in the CC direction will remain a challenging
task for MRI-only planning since the geometric accuracy decreases ra-
pidly farther away from the isocentre of MRI device. Within the study
population, we found that the maximal useful FOV for one station scan
was 300 mm in CC direction, while for longer FOV a two-station scan is
required. For the longer FOV, the image shutter prevented analysis of
geometric accuracy and body outline difference. The patient motion
causes artifacts in the mDIXON image that may hamper accurate de-
tection of body outline. Increasing the FOV in the CC direction with an
acceptable scan time for preventing the organ motion and more robust
motion management in the abdomen region will also remain challenges
for general pelvis sCT solutions and they need to be examined further.
In this study, only a subgroup of the cohort was included in the
positioning study. Consequently, the number of patients per cancer
group was small. However, the positioning protocol for planar kV-
image to DRR registration is similar between the groups enabling
general conclusions to be drawn from these results. Furthermore, for
the bone registration using CBCT images the procedure is similar be-
tween various cancer groups. On the contrary, the soft-tissue-based
CBCT registration is different between the groups, and thus our con-
clusions apply only to prostate cancer patients. Further studies are re-
quired to assess the feasibility of other cancer types.
The implanted ﬁducial marker-based workﬂow was not included in
the study although it is the clinical practice for the majority of the
patients at our institution and a combination of ﬁducial marker align-
ment and soft-tissue analysis is currently the most effective and widely
available approach to ensuring the accuracy in image-guided EBRT of
prostate [32] . The use of ﬁducial markers for position veriﬁcation of
prostate has been evaluated for the ﬁrst MRCAT algorithm (sCTb) by
Tyagi et al. [13] . Thus, the re-evaluation was not considered relevant
since the use of continuous HU values was not expected to impact seed-
based workﬂow. In addition, the localization of ﬁducial markers from
MR images has been evaluated to be sufficiently accurate and com-
parable to CT-based ﬁducial marker localization [33,34] .
This study advances research and supports the future clinical im-
plementation of sCT for general pelvic anatomy. It has been shown that
continuous HU sCT was required for the accurate position veriﬁcation
of patients, particularly when using the soft-tissue-based registration
strategies. However, the method based only on four bulk HU values was
dosimetrically adequate. The use of sCT for pelvic cancer patients can
be used to obtain the required dosimetric and geometric accuracy.
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